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Synthesis of Enantiopure 1-Aryl-1-butylamines and 1-Aryl-3-butenylamines
by Diastereoselective Addition of Allylzinc Bromide to Imines Derived from
(R)-Phenylglycine Amide
Jan Dalmolen,[a] Marcel van der Sluis,[b] Jose´ W. Nieuwenhuijzen,[b] Auke Meetsma,[a] Ben de
Lange,[c] Bernard Kaptein,[c] Richard M. Kellogg,*[b] and Quirinus B. Broxterman[c]
Keywords: Allylation / Asymmetric synthesis / Chiral auxiliaries / Diastereoselectivity
The synthesis of enantiopure 1-aryl-1-butylamines via a
highly diastereoselective addition of allylzinc bromide to im-
ines derived from (R)-phenylglycine amide is reported. These
are synthesised by a three-step procedure, which involves:
(a) formation of the chiral imines; (b) asymmetric addition of
the allylzinc reagent; (c) removal of the chiral auxiliary by
Introduction
Enantiomerically pure amines with a chiral centre at the
α-position are valuable synthons in the synthesis of biologi-
cally active natural products and compounds of pharma-
ceutical interest.[1] One of the strategies used to obtain chi-
ral amines is an asymmetric 1,2-addition of nucleophiles
to the electrophilic CN imino group of chiral aldimines
(Scheme 1). Other methods include e.g. catalytic asymmet-
ric addition of dialkylzinc to imines,[2] diastereoselective re-
duction of chiral imines,[3] enantioselective reduction of
prochiral imines[4] and oximes,[5] or use of a transaminase.[6]
Scheme 1. Synthesis of enantiomerically enriched primary amines
by asymmetric 1,2-addition
Enantiomerically pure imines can be generated, in most
cases fairly easily, by condensation of an enantiopure amine
R2NH2 used as a (readily available) chiral auxiliary, with
the corresponding carbonyl compound. High asymmetric
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means of a reductive or non-reductive method. The reductive
method provides 1-aryl-1-butylamines whereas the non-re-
ductive method preserves the double bond to afford 1-aryl-
3-butenylamines.
( Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim,
Germany, 2004)
induction during the addition can be achieved by using im-
ines derived from chiral auxiliaries such as α-arylethylam-
ines,[7] β-amino alcohols, β-alkoxy amines, and α-amino
acid esters.[8] A common feature of the latter three auxiliar-
ies is the presence of a second heteroatom, which is capable
of rigidifying the transition state of the 1,2-addition
through chelation.[7] This effect is also referred to as ‘‘chel-
ation control’’.[9] Drawbacks are the availability, in some
cases, of only one enantiomer, high costs, low regioselectiv-
ity in the cleavage of the auxiliary, immolative removal and/
or the need of removal of these auxiliaries by procedures
unsuitable for large-scale preparations, such as oxidation
with [Pb(OAc)4][10] or treatment with HIO4/MeNH2.[7,8b]
In this paper we report the preparation of easily access-
ible substituted 1-aryl-1-butylamines and 1-aryl-3-butenyla-
mines, which we intend to use as new families of resolving
agents in ‘‘Dutch Resolution experiments’’.[11] A metal-me-
diated Cope reaction (Figure 1) is a key element of the syn-
thesis. There is extensive precedent for such reac-
tions.[12a,13b,13g]
Figure 1. Metal-mediated Cope reaction
Synthesis of Enantiopure 1-Aryl-1-butylamines and 1-Aryl-3-butenylamines FULL PAPER
In a preliminary publication, optically pure (R)-phenyl-
glycine amide [(R)-PGA (1)] was shown to be a highly ef-
ficient chiral auxiliary for this process.[12a] (R)-PGA (1) re-
adily forms imines with aldehydes.[12] These imines, capable
of forming rigid chelated intermediates, have been subjected
to addition of allylzinc reagents. Both reductive and non-
reductive methods for the removal of the chiral auxiliary
have been used to obtain the desired substituted enantiom-
erically pure primary amines. Finally, the selectivity of
cleavage of the chiral auxiliary in the reductive removal has
been investigated.
Results and Discussion
Diastereoselective Allylation of (R)-PGA Aldimines
Benzaldimines (R)-223 are easily obtained in excellent
yields and 99% ee[14] by stirring a mixture of (R)-PGA (1)
in CH2Cl2 with the corresponding substituted benzaldehyde
overnight at room temperature (Table 1).[12] No catalyst is
required and, in all cases, chemically pure products were
obtained. This conclusion is based on the fact that clean
singlets for both the proton adjacent to the carboxamide
group as well as the imine proton are observed in the 1H
NMR spectra. Imines 223 are crystalline and have sharp
Table 1. Formation of (R)-PGA imines 223 by condensation with substituted benzaldehydes and the formation of (R,R)-PGA allyl-
amines 2445 by addition of allylzinc bromide
Entry Imine Ar Yield (%)[a] Allylamine Yield (%)[a] dr (R,R):(R,S)[b]
1 2 C6H5 99 24 99 99:1
2 3 o-Me-C6H4 99 25 93 99:1
3 4 m-Me-C6H4 97 26 99 99:1
4 5 p-Me-C6H4 99 27 97 99:1
5 6 o-OMe-C6H4 93 28 98 99:1
6 7 m-OMe-C6H4 81 29 99 99:1
7 8 p-OMe-C6H4 98 30 99 99:1
8 9 o-F-C6H4 97 31 99 98:2
9 10 m-F-C6H4 96 32 97 98:2
10 11 p-F-C6H4 95 33 94 99:1
11 12 o-Cl-C6H4 97 34 98 97:3
12 13 m-Cl-C6H4 98 35 83 98:2
13 14 p-Cl-C6H4 95 36 98 99:1
14 15 o-Br-C6H4 99 37 98 99:1
15 16 m-Br-C6H4 98 38 99 99:1
16 17 p-Br-C6H4 99 39 95 99:1
17 18 o-Ph-C6H4 85 40 89 99:1
18 19 m-Ph-C6H4 89 41 85 99:1
19 20 p-Ph-C6H4 95 42 99 99:1
20 21 o-NO2-C6H4 97 43 99 99:1
21 22 m-NO2-C6H4 98 44 96 99:1
22 23 p-NO2-C6H4 92 45 93 99:1
[a] Isolated yield. [b] Diastereoselectivity values were determined with 1H NMR spectroscopy.[16]
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melting points. On the basis of thermodynamic consider-
ations the products should all have the E-configuration.
The phenyl-substituted benzaldehydes for the formation
of imines 1820 were prepared from the corresponding
bromobenzaldehydes by a Suzuki coupling using 10% pal-
ladium on carbon as a catalyst.[15]
The addition of benzaldimines (R)-223 to preformed
allylzinc bromide (1.5 equiv.) in THF at 0 °C afforded the
(R,R)-PGA allylamines 2445 in yields of up to 99% or
higher and diastereoselectivities of at least 97:3 (Table 1). In
all cases, the dr could be increased to more than 99:1 by
recrystallisation from acetone/hexane (1:20). It has been
demonstrated previously for the case of 24 that the addition
proceeds without any racemisation of the chiral auxili-
ary.[12b] Although, this has not been explicitly checked, the
ee’s of the end products indicate that this is also the case
for the other addition products 2445 (vide supra).
The addition reaction has also been performed under
Barbier-type[17] conditions with imines 211 and 1820,
giving similar results. In this procedure the imines are
stirred with zinc and allyl bromide in THF at 0 °C and the
reaction mixture is allowed to warm to room temperature.
This procedure in our experience is considerably easier from
an experimental point of view. Imines 1217 undergo par-
tial halogen exchange under these conditions.
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The high diastereoselectivity of the allylation of the (R)-
PGA imines can be rationalised by chelation control, as
shown in Figure 2.[13] The two heteroatoms of the amide-
imine moiety chelate the zinc atom of the allylzinc reagent
to form a five-membered ring.[7,9] Simultaneously, a six-
membered, chair-like transition state is formed with the al-
lylic system and the CN double bond of the imine. The
re-face 1,2-addition proceeds in a concerted fashion via an
allylic aza-Cope-like rearrangement. Arguments and exper-
imental evidence in support of this mechanistic model have
been given previously.[12a]
Figure 2. Proposed chelation controlled addition of allylzinc
bromide to (R)-PGA imines
The (R,R)-configuration of the adducts was unambigu-
ously confirmed by X-ray crystallographic analysis.[12a] The
absolute configuration of adducts 2445 was assigned by
analogy.
Reductive Removal of the Chiral Auxiliary
The chiral auxiliary can easily be removed by selective
catalytic debenzylation using H2 and 10% palladium on car-
bon.[18,19] However, since PGA allylamines 2445 are ‘‘di-
N-benzylic’’, reductive removal of the auxiliary by catalytic
hydrogenation may cleave either of the two benzylic CN
Scheme 2. Selectivity of cleavage in the catalytic hydrogenation process; reagents and conditions: isopropanol/H2O/AcOH, H2, PdC
(10%)
Table 2. Regioselective cleavage of the chiral auxiliary and generation of primary 1-aryl-1-butylamines 4757 by catalytic hydrogenation
Entry Allylamine Ar Butylamine Yield (%)[a] Selectivity a:b[b]
1 24 C6H5 47 70 91:9
2 25 o-Me C6H4 48 95 99:1
3 26 m-Me C6H4 49 92 99:1
4 27 p-Me C6H4 50 91 99:1
5 28 o-OMe C6H4 51 91 99:1
6 29 m-OMe C6H4 52 89 98:2
7 30 p-OMe C6H4 53 89 97:3
8 31 o-F C6H4 54 88 98:2
9 32 m-F C6H4 55 58 99:1
10 33 p-F C6H4 56 79 99:1
11 40 o-Ph C6H4 57 87 97:3
12 41 m-Ph C6H4 80 nd[c] 1:99[d]
13 42 p-Ph C6H4 81 nd 1:99[d]
[a] Isolated yield. [b] Regioselectivity values determined with 1H NMR spectroscopy. [c] nd: Not determined. [d] Confirmed by mass analysis,
1H and 13C NMR.
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bonds via route a or route b (Scheme 2). In addition, this
reductive removal of the chiral auxiliary leads to the loss of
the allylic functionality.
Hydrogenolytic cleavage via route b leads to the unde-
sired substituted 1-butylbenzene 46, whereas cleavage via
route a provides the desired saturated 1-phenylbutylamines
(R)-4757.
There is not much literature precedent to allow prediction
whether path a or path b will dominate, but steric as well
as electronic effects might influence the outcome of the hy-
drogenolysis. With this in mind we began a systematic inves-
tigation. Initially 2-(benzylamino)-2-phenylacetamide
(58)[20] was examined as a model compound (Scheme 3) and
we were very much encouraged to observe only benzyla-
mine and phenylacetamide (59) (route a) and no (R)-PGA
and toluene (route b).
Scheme 3. Regioselectivity in the debenzylation process of 58; re-
agents and conditions: Et2O, H2, PdC (10%)
Most probably the electron-withdrawing carboxamide
group withdraws some electron density from the σ-bond in-
volved in path a by means of inductive interactions, and
one could well expect this σ-bond to be a better hydrogen
acceptor.
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The selectivities (a:b) for products 2442 were deter-
mined by 1H NMR spectroscopy. Analysis of 1H NMR
spectra of the reaction mixtures revealed that cleavage ac-
cording to route a gave rise to a characteristic triplet of the
benzylic CH group between δ  3.94.2 ppm, and com-
petitive cleavage according to route b gave rise to a triplet
of the benzylic CH2 group at approx. δ  2.52.8 ppm. By
comparing the ratio of the integrals for both signals, the
selectivity for each case could be determined (Table 2). For
instance, in the case of the unsubstituted PGA allylamine
24 the selectivity of the cleavage process is 91:9 in favour of
path a (Figure 3).
Figure 3. Selectivity of cleavage of homoallylamine 24 after hydro-
genation
The PGA allylamines 2433 and 40 showed pleasingly
high selectivities in cleavage of the CN bond of the chiral
auxiliary via route a. The free primary 1-arylbutylamines
(R)-4757 were obtained in yields of up to 95%. The selec-
tivities of the cleavage range from 91:1 up to more than
99:1, depending on the substituent. The earlier work of
Baltzly and Russel[18c] showed that the electronic nature of
the substituent rather than its position is critical in its effect
on the regioselectivity of debenzylation. Most substituents
studied here are electron donating and increase the stability
of the N-benzyl linkage, promoting cleavage according to
route a.
Attempts to convert the chloro- and bromo-substituted
PGA allylamines 3439 into the corresponding substituted
amines were frustrated by dehalogenation, which occurred
prior to debenzylation,[18b,18e] as was established by NMR
spectroscopy and mass analysis. In all cases the only prod-
uct isolated was 1-butyl-1-phenylamine (47).
Scheme 4. Regioselectivity of the nitro-substituted PGA allylamines under reductive conditions; reagents and conditions: isopropanol/
H2O/AcOH, H2, PdC (10%)
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In the cases of the meta- and para-phenyl-substituted
PGA allylamines (entries 12 and 13), the regioselectivity
strongly disfavours the desired products. As described by
Baltzly and Buck,[18a] for reasons that are still unclear the
phenyl group labilizes the nearby N-benzyl linkage, which
results in the observed regioselectivity towards the un-
wanted by-product. We postulate that in the case of the
ortho-phenyl-substituted homoallylamine (40, entry 11), the
bulky phenyl group shields the nearby benzylic CN bond
and reduction takes place from the less-hindered side, yield-
ing the desired arylbutylamine 57 as the major product.
In the case of the catalytic hydrogenation of the nitro-
substituted PGA allylamines (R,R)-4345, the only prod-
ucts obtained were the aniline derivatives 6163
(Scheme 4). The NO2 moiety is reduced prior to debenzyl-
ation. Apparently, the electron-withdrawing effect of the
cationic NH3 group of intermediate 60[21] weakens the ne-
arby N-benzylic bond, resulting in the observed regioselec-
tivity towards 6163.
Non-Reductive Removal of the Chiral Auxiliary
The bromo-, chloro-, nitro- and phenyl-substituted PGA
allylamines were subjected to a non-reductive deprotection
procedure as reported recently.[12a] The conversion of the
PGA protected allylamines (R,R)-3442 into the nitrile 64
is based on the dehydration of the amide moiety
(Scheme 5).[22] This dehydration is performed by treating
the amide with Vilsmeier reagent [ClCHN(CH3)2 Cl]
Scheme 5. Non-reductive removal of the chiral auxiliary; reagents
and conditions: (a) Vilsmeier reagent [ClCHN(CH3)2Cl, 1.5
equiv.], CH2Cl2, NEt3 (1 equiv.), 0 °C to room temp.; (b) K2CO3
(2 equiv.), EtOH, reflux, 2 h; (c) NH2OH.HCl, THF/H2O, room
temp., overnight; (d) H2, PtC (5%), EtOAc, 1 h
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Table 3. Conversion of the PGA-protected allylamines (R,R)-3442 into (R)-1-aryl-1-butylamines 7481
Entry Allylamine Ar Butenylamine Yield (%)[a] Butylamine Yield (%)[b] er (R:S)
1 34 o-ClC6H4 66 51 74 91 99:1[c]
2 35 m-ClC6H4 67 42 75 99 99:1[c]
3 36 p-ClC6H4 68 51 76 99 99:1[c]
4 37 o-BrC6H4 69 32 77 99 99:1[c]
5 38 m-BrC6H4 70 40 78 99 99:1[c]
6 39 p-BrC6H4 71 48 79 85 99:1[c]
7 41 m-PhC6H4 72 40 80 93 nd[d]
8 42 p-PhC6H4 73 49 81 95 nd
[a] Isolated yield after 3 steps. [b] Isolated yield. [c] For analysis by HPLC[23] the corresponding arylbutylamine was dehalogenated to 1-
phenyl-1-butylamine 47 with H2, PdC (10 %). [d] nd: Not determined.
in combination with two equivalents of triethylamine. In a
general procedure, the Vilsmeier reagent is formed in situ
by reaction of DMF with oxalyl chloride in CH2Cl2 at 0
°C. A solution of the amide in CH2Cl2 is then added drop-
wise to the Vilsmeier reagent.
Although the stereocentre of the chiral auxiliary partially
epimerises under these conditions, the deprotection pro-
ceeds with full retention of configuration at the homoallylic
stereocentre — the observation that enantiomerically pure
amines are obtained after deprotection makes clear that no
racemisation takes place (Table 3, entries 16).
The conversion of nitrile 64 into the N-benzylidene-pro-
tected arylbutenylamine (R)-65 is based on the elimination
of HCN in a retro-Strecker fashion. Treating the nitrile with
two equivalents of K2CO3 for two hours in refluxing etha-
nol results in full elimination of HCN.[24] Hydroxylamine
hydrochloride in aqueous THF[25] is the reagent of choice
for the room temperature hydrolysis of the N-benzylidene-
protected arylbutenylamine 65. Arylbutenylamines (R)-
6673 were obtained in 4060% overall yields (Table 3).
Probably because of the sensitive nature of the NO2 group,
the non-reductive removal failed for all the nitro-substi-
tuted substrates.
With satisfactory results for the synthesis of the arylbut-
enylamines 6673 in hand, we undertook further reduction
of the double bond by catalytic hydrogenation with H2 in
the presence of 5% platinum on carbon,[26] which gave the
corresponding saturated substituted 1-arylbutylamines (R)-
7481 in almost quantitative yields. Samples were taken
during the reaction and analysed by 1H and 13C NMR spec-
troscopy to follow the reaction: after one hour the uptake
of one mol of H2 was complete. In case of reduction of the
bromo-substituted phenylbutylamines (R)-6971 longer re-
action times resulted in a considerable amount of the dehal-
ogenated products.
Scheme 7. Reagents and conditions: (a) HNO3 (85%), 5 °C, 4 h; (b) HCONH2/HCO2H, ∆; (c) HCl, ∆; (d) (S)-phencyphos 88, 2-
butanone/H2O, ∆; analysis by HPLC[23]
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Synthesis of Nitro-Substituted Phenylbutylamines
Owing to the failure of other approaches to the nitro-
substituted phenylbutylamines an alternative method was
examined. Nitration of enantiomerically pure phenylbu-
tylamine (R)-47 with nitric acid[27] provided a mixture con-
taining (R)-1-butyl-1-(ortho-nitrophenyl)amine [(R)-82] and
(R)-1-butyl-1-(para-nitrophenyl)amine [(R)-83] in a ratio of
22:78 (Scheme 6). This mixture of regioisomers was used
without further purification.
Scheme 6. Reagents and conditions: HNO3 (85%), 5 °C, 4 h
The meta-nitro-substituted phenylbutylamine (R)-87 was
prepared by a Leuckart reductive amination of 85, followed
by resolution of the racemic 87 (Scheme 7). The m-nitrobu-
tyrophenone 85 was obtained by nitration of butyro-
phenone 84 with HNO3 (85%).[28] The best yield of 85 was
obtained by nitration at 5 °C. The main product was the
meta-nitro compound, which was generally accompanied by
a small and variable amount of the ortho isomer. From this
mixture, the meta-nitro compound is easily separated by
crystallisation and obtained pure in 55% yield.
In the first step of the Leuckart reaction, the imine is
formed in situ with formamide followed by a reduction with
formic acid. Formamide 86 is subsequently hydrolysed with
10% HCl and affords the racemic free amine 87 in greater
than 99% yield.
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Figure 4. Structure of (S)-phencyphos (88) and crystal structures of (S)-88 (left) and (R)-87 (right)
Subsequently, the racemic butyl(meta-nitrophenyl)amine
needed to be resolved. Several 1 mmol test experiments
were performed [29] and it turned out that butyl(meta-nitro-
phenyl)amine (87) could successfully be resolved with the
cyclic phosphoric acid (S)-88, known by the trivial name of
(S)-phencyphos.[30]
X-ray crystallographic analysis unambiguously showed
that after resolution with (S)-88, the chiral centre C21 of
87 had the desired (R)-configuration. (Figure 4).[31] After
liberation, the free amine (R)-87 was obtained in 24% yield
and greater than 99% ee.
Conclusions
The results presented here further illustrate the versatility
of (R)-phenylglycine amide (1) as a chiral auxiliary for the
preparation of enantiomerically pure phenylbutylamines
starting from substituted benzaldehydes. Allylation is read-
ily accomplished with allylzinc bromide, prepared in situ
from relatively inexpensive allyl bromide. The chiral auxili-
ary is conveniently removed under either reductive or non-
reductive conditions. In the reduction of the bromo-substi-
tuted phenylbutenylamines, dehalogenation is a competing
reaction. The sensitivity of the nitro group prevented the
synthesis of the desired nitro-substituted phenylbutylamines
using the reductive- or non-reductive removal of the chiral
auxiliary. Alternative routes were used to synthesise these
compounds.
Since also (S)-phenylglycine amide is readily available,
the opposite configuration of the described products can be
generated at will. Dutch Resolution experiments with this
potential new family of substituted phenylbutylamines, as
well as the family based on the unsaturated primary homo-
allylamines, are currently under investigation.
Experimental Section
General Information: Reagents were purchased from Aldrich
Chemical Company and were used without further purification.
(R)-Phenylglycine amide was provided by DSM (Geleen, The
Eur. J. Org. Chem. 2004, 15441557 www.eurjoc.org  2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 1549
Netherlands). THF was freshly distilled from benzophenone/so-
dium. Zinc wool was cut prior to use or zinc granules (30 100
mesh) were used. Optical rotations were measured at ambient tem-
peratures using a PerkinElmer 241 polarimeter. Melting points
were measured on a Büchi B-545 or a Mettler FP1 equipped with
a Mettler FP-21 microscope, and were uncorrected. 1H NMR spec-
tra were recorded on either a Varian VXR-300 spectrometer
(300 MHz) or a Varian Gemini Spectrometer (200 MHz). 13C
NMR spectra were recorded on a Varian Gemini 200 (50 MHz).
Chemical shifts are denoted in parts per million (δ) and are refer-
enced to the residual protonated solvent. The 1H and 13C NMR
spectra of compounds 2, 24 and 47 were as previously reported.[12a]
Typical Procedure for the Synthesis of (R)-PGA-aldimines 223:
The substituted benzaldehyde (200 mmol) was added to a suspen-
sion of (R)-phenylglycine amide (200 mmol, 30.0 g) in CH2Cl2
(200 mL) at ambient temperature. The reaction mixture was stirred
overnight at room temperature. After removal of the CH2Cl2, the
residual solid was washed with acetone/hexane (1:20) or was recrys-
tallised once from acetone/hexane (1:20). In all cases only the more
stable all-E-isomer was obtained, as judged from the presence of
only one vinyl proton in the 1H NMR spectrum.
(2R)-2-{[(E)-(2-Methylphenyl)methylidene]amino}-2-phenylacet-
amide (3): Colourless needles, 99% yield. M.p. 168.0168.4 °C.
1H NMR (200 MHz, CDCl3/[D6]DMSO): δ  2.53 (s, 3 H), 4.99
(s, 1 H), 5.91 (br. s, 1 H), 7.01 (br. s, 1 H), 7.197.53 (m, 8 H),
7.95 (dd, J  8.0, J  1.7 Hz, 1 H), 8.61 (s, 1 H) ppm. 13C NMR
(50 MHz, CDCl3/[D6]DMSO): δ  17.9 (q), 76.4 (d), 125.0 (d),
126.3 (d), 126.7 (d), 127.2 (d), 129.7 (d), 129.8 (d), 132.4 (s), 137.0
(s), 139.4 (s), 160.3 (d), 171.6 (s) ppm. C16H16N2O (252.3): calcd.
C 76.16, H 6.39, N 11.10; found C 75.78, H 6.37, N 11.09. MS
(CI): m/z  253 [M  H].
(2R)-2-{[(E)-(3-Methylphenyl)methylidene]amino}-2-phenylacet-
amide (4): Pale yellow needles, 97% yield. M.p. 118.0118.9 °C. 1H
NMR (200 MHz, CDCl3): δ  2.41 (s, 3 H), 4.98 (s, 1 H), 5.67 (br.
s, 1 H), 7.05 (br. s, 1 H), 7.267.64 (m, 9 H), 8.21 (s, 1 H) ppm.
13C NMR (50 MHz, CDCl3): δ  18.9 (q), 74.5 (s), 123.5 (s), 124.7
(d), 125.5 (d), 126.1 (d), 126.2 (d), 126.3 (d), 129.9 (d), 132.9 (s),
136.0 (s), 136.7 (s), 161.0 (d), 171.5 (s) ppm. C16H16N2O (252.3):
calcd. C 75.16, H 6.39, N 11.10; found C 75.09, H 6.30, N 11.11.
MS (CI): m/z  253 [M  H].
(2R)-2-{[(E)-(4-Methylphenyl)methylidene]amino}-2-phenylacet-
amide (5): Colourless prisms, 99% yield. M.p. 153.9 °C. 1H NMR
(200 MHz, CDCl3): δ  2.40 (s, 3 H), 4.96 (s, 1 H), 5.68 (br. s, 1
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H), 7.05 (br. s, 1 H), 7.227.51 (m, 8 H), 7.69 (d, J  7.6 Hz, 2
H), 8.27 (s, 1 H) ppm. 13C NMR (50 MHz, CDCl3): δ  20.1 (q),
75.4 (d), 125.8 (d), 126.4 (d), 127.0 (d), 127.2 (d), 128.0 (d), 131.4
(s), 137.9 (s), 140.5 (s), 161.6 (d), 173.0 (s) ppm. C16H16N2O
(252.3): calcd. C 75.16, H 6.39, N 11.10; found C 76.06, H 6.41, N
11.09. MS (CI): m/z  253 [M  H].
(2R)-2-{[(E)-(2-Methoxyphenyl)methylidene]amino}-2-phenylacet-
amide (6): Colourless plates, 93% yield. M.p. 174.3175.2 °C. 1H
NMR (200 MHz, CDCl3): δ  3.85 (s, 1 H), 4.98 (s, 1 H), 5.93 (br.
s, 1 H), 6.897.04 (m, 3 H), 7.267.52 (m, 6 H), 8.07 (dd, J  7.6,
J  1.7 Hz, 1 H), 8.77 (s, 1 H) ppm. 13C NMR (50 MHz, CDCl3):
δ  54.0 (q), 75.9 (d), 109.7 (d), 119.2 (d), 122.4 (s), 125.7 (d),
125.8 (d), 126.3 (d), 127.1 (d), 131.3 (d), 138.1 (s), 157.7 (s), 157.8
(d), 172.9 (s) ppm. C16H16N2O2 (268.3): calcd. C 71.62, H 6.01, N
10.44; found C 71.54, H 5.97, N 10.47. MS (CI): m/z  269 [M
 H].
(2R)-2-{[(E)-(3-Methoxyphenyl)methylidene]amino}-2-phenylacet-
amide (7): Colourless needles, 81% yield. M.p. 131.9132.4 °C. 1H
NMR (200 MHz, CDCl3/[D6]DMSO): δ  3.64 (s, 3 H), 4.74 (s, 1
H), 6.07 (br. s, 1 H), 6.786.82 (m, 2 H), 6.88 (br. s, 1 H),
7.047.27 (m, 6 H), 8.07 (s, 1 H) ppm. 13C NMR (50 MHz, CDCl3/
[D6]DMSO): δ  55.4 (q), 76.9 (d), 112.6 (d), 117.6 (d), 127.0 (d),
127.2 (d), 128.0 (d), 128.7 (d), 129.8 (d), 136.8 (s), 139.2 (s), 159.9
(s), 163.2 (d), 174.1 (s) ppm. C16H16N2O2 (268.3): calcd. C 71.62,
H 6.01, N 10.44; found C 71.62, H 6.09, N 10.41. MS (CI): m/z 
269 [M  H].
(2R)-2-{[(E)-(4-Methoxyphenyl)methylidene]amino}-2-phenylacet-
amide (8): Yellow solid, 98% yield. M.p. 92.593.3 °C. 1H NMR
(200 MHz, CDCl3): δ  3.85 (s, 3 H), 5.81 (br. s, 1 H), 4.94 (1H),
6.95 (d, J  8.8 Hz, 2 H), 7.06 (br. s, 1 H), 7.267.50 (m, 5 H),
7.75 (d, J  8.8 Hz, 2 H), 8.23 (s, 1 H) ppm. 13C NMR (50 MHz,
CDCl3): δ  53.9 (q), 75.4 (d), 112.6 (d), 125.8 (d), 126.4 (d), 126.9
(s), 127.2 (d), 128.7 (d), 138.1 (s), 160.8 (s), 161.0 (d), 173.1 (s)
ppm. C16H16N2O2 (268.3): calcd. C 71.62, H 6.01, N 10.44; found
C 71.30, H 5.95, N 10.44. MS (CI): m/z  269 [M  H].
(2R)-2-{[(E)-(2-Fluorophenyl)methylidene]amino}-2-phenylacetamide
(9): Pale yellow needles, 97% yield. M.p. 153.7154.2 °C. 1H NMR
(300 MHz, CDCl3/[D6]DMSO): δ  4.80 (s, 1 H), 6.28 (br. s, 1 H),
6.80 (br. s, 1 H), 6.91 (t, J  9.3 Hz, 1 H), 7.04 (t, J  7.3 Hz, 1
H), 7.107.30 (m, 6 H), 7.90 (t, J  7.3 Hz, 1 H), 8.43 (s, 1 H)
ppm. 13C NMR (50 MHz, CDCl3/[D6]DMSO): δ  75.0 (d), 113.4
(d, 2JC,F  22.0 Hz), 120.5 (s, 2JC,F  9.8 Hz), 121.8 (d, 3JC,F 
3.7 Hz), 124.7 (d), 125.2 (d, 4JC,F  2.4 Hz), 125.4 (d), 126.1 (d),
130.7 (d, 3JC,F  9.8 Hz), 136.7 (s), 154.0 (d, 3JC,F  4.9 Hz), 159.8
(s, 1JC,F  253.9 Hz), 171.1 (s) ppm. C15H13FN2O (256.3): calcd.
C 70.30, H 5.10, N 10.90; found C 70.40, H 5.04, N 10.87. MS
(CI): m/z  257 [M  H].
(2R)-2-{[(E)-(3-Fluorophenyl)methylidene]amino}-2-phenylacetamide
(10): Yellow plates, 96% yield. M.p. 121.6121.9 °C. 1H NMR
(300 MHz, CDCl3/[D6]DMSO): δ  4.71 (s, 1 H), 6.39 (br. s, 1 H),
6.74 (br. s, 1 H), 6.91 (d, J  8.2 Hz, 1 H), 7.027.28 (m, 7 H),
7.34 (d, J  9.2 Hz, 1 H), 8.04 (s, 1 H) ppm. 13C NMR (50 MHz,
CDCl3/[D6]DMSO): δ  74.4 (d), 111.6 (d, 2JC,F  23.2 Hz), 115.7
(d, 2JC,F  20.8 Hz), 122.3 (d, 3JC,F  2.4 Hz), 124.6 (d), 125.3 (d),
126.1 (d), 127.7 (d, 3JC,F  7.3 Hz), 135.1 (s, 3JC,F  7.3 Hz), 136.7
(s), 159.1 (d, 4JC,F  2.4 Hz), 160.3 (s, 1JC,F  246.6 Hz), 170.9 (s)
ppm. C15H13FN2O (256.3): calcd. C 70.30, H 5.11, N 10.93; found
C 70.00, H 5.23, N 10.81. MS (CI): m/z  257 [M  H].
(2R)-2-{[(E)-(4-Fluorophenyl)methylidene]amino}-2-phenylacetamide
(11): Colourless plates, 95% yield. M.p. 119.4120.5 °C. 1H NMR
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(200 MHz, CDCl3): δ  4.98 (s, 1 H), 5.85 (br. s, 1 H), 6.96 (br. s,
1 H), 7.097.50 (m, 10 H), 7.777.84 (m, 2 H), 8.28 (s, 1 H) ppm.
13C NMR (50 MHz, CDCl3): δ  75.4 (d), 114.2 (d), 114.4 (d,
2JC,F  21.7 Hz), 125.7 (d), 126.5 (d), 127.3 (d), 128.9 (d), 129.0
(d, 3JC,F  8.8 Hz), 130.2 (s), 137.6 (s), 160.4 (d), 163.3 (s, 1JC,F 
252.5 Hz), 172.6 (s) ppm. C15H13FN2O (256.3): calcd. C 70.30, H
5.10, N 10.90; found C 70.38, H 5.14, N 10.83. MS (CI): m/z 
257 [M  H].
(2R)-2-{[(E)-(2-Chlorophenyl)methylidene]amino}-2-phenylacet-
amide (12): Colourless needles, 97% yield. M.p. 170.3171.0 °C.
1H NMR (200 MHz, CDCl3): δ  5.05 (s, 1 H), 8.76 (s, 1 H), 8.13
(d, J  6.1 Hz, 1 H), 7.267.51 (m, 8 H), 6.94 (br. s, 1 H), 6.20
(br. s, 1 H) ppm. 13C NMR (50 MHz, CDCl3): δ  75.8 (d), 125.5
(d), 125.7 (d), 126.6 (d), 126.9 (d), 127.3 (d), 128.6 (d), 130.9 (d),
134.5 (s), 137.9 (s), 158.7 (d), 172.4 (s) ppm. C15H13ClN2O (272.7):
calcd. C 66.05, H 4.80, N 10.27; found C 65.92, H 4.81, N 10.31.
MS (CI): m/z (%)  273 (100.0) [M  H], 275 (34.5) [M  H].
(2R)-2-{[(E)-(3-Chlorophenyl)methylidene]amino}-2-phenylacet-
amide (13): Colourless plates, 98% yield. M.p. 119.4120.9 °C. 1H
NMR (300 MHz, CDCl3): δ  4.94 (s, 1 H), 5.83 (br. s, 1 H), 6.90
(br. s, 1 H), 7.217.42 (m, 7 H), 7.56 (d, J  7.3 Hz, 1 H), 7.80 (s,
1 H), 8.29 (s, 1 H) ppm. 13C NMR (50 MHz, CDCl3): δ  76.9
(d), 127.1 (d), 127.2 (d), 127.8 (d), 128.1 (d), 128.8 (d), 130.0 (d),
131.5 (d), 124.9 (s), 137.0 (s), 138.9 (s), 161.9 (d), 173.6 (s) ppm.
C15H13ClN2O (272.7): calcd. C 66.05, H 4.80, N 10.27; found C
65.77, H 4.89, N 10.36. MS (CI): m/z  273 (100.0) [M  H],
275 (36.1) [M  H].
(2R)-2-{[(E)-(4-Chlorophenyl)methylidene]amino}-2-phenylacet-
amide (14): Pale yellow plates, 95% yield. M.p. 153.4154.2 °C. 1H
NMR (200 MHz, CDCl3/[D6]DMSO): δ  4.83 (s, 1 H), 6.28 (br.
s, 1 H), 6.83 (br. s, 1 H), 7.147.36 (m, 7 H), 7.63 (d, J  8.6 Hz,
2 H), 8.15 (s, 1 H) ppm. 13C NMR (50 MHz, CDCl3/[D6]DMSO):
δ  75.5 (d), 125.7 (d), 126.4 (d), 127.1 (d), 127.4 (d), 128.1 (d),
132.3 (s), 135.8 (s), 137.7 (s), 160.2 (d), 172.1 (s) ppm.
C15H13ClN2O (272.7): calcd. C 66.05, H 4.80, N 10.27; found C
65.76, H 4.93, N 10.25. MS (CI): m/z  273 (100.0) [M  H],
275 (34.8) [M  H].
(2R)-2-{[(E)-(2-Bromophenyl)methylidene]amino}-2-phenylacet-
amide (15): Pale yellow needles, 99% yield. M.p. 168.3168.7 °C.
1H NMR (300 MHz, CDCl3/[D6]DMSO): δ  5.02 (s, 1 H), 5.02
(br. s, 1 H), 6.88 (br. s, 1 H), 7.217.36 (m, 5 H), 7.43 (d, J 
7.0 Hz, 2 H), 7.54 (d, J  8.1 Hz, 1 H), 8.07 (dd, J  7.7, J 
1.8 Hz, 1 H), 8.65 (s, 1 H) ppm. 13C NMR (50 MHz, CDCl3/
[D6]DMSO): δ  76.5 (d), 124.6 (s), 127.4 (d), 127.5 (d), 128.0 (d),
128.4 (d), 129.3 (d), 133.0 (d), 133.1 (d), 133.7 (s), 140.0 (s), 160.9
(d), 172.2 (s) ppm. C15H13BrN2O (317.2): calcd. C 56.80, H 4.13,
N 8.83; found C 56.89, H 4.22, N 9.08. MS (CI): m/z  317 (100.0)
[M  H], 319 (98.3) [M  H].
(2R)-2-{[(E)-(3-Bromophenyl)methylidene]amino}-2-phenylacet-
amide (16): Colourless plates, 98% yield. M.p. 135.0136.3 °C. 1H
NMR (300 MHz, CDCl3): δ  4.94 (s, 1 H), 5.68 (br. s, 1 H), 6.90
(br. s, 1 H), 7.207.33 (m, 5 H), 7.41 (d, J  7.0 Hz, 1 H), 7.54
(d, J  8.6 Hz, 1 H), 7.61 (d, J  7.7 Hz, 1 H), 7.96 (s, 1 H), 8.20
(s, 1 H) ppm. 13C NMR (50 MHz, CDCl3): δ  74.5 (d), 120.5 (s),
124.7 (d), 125.1 (d), 125.6 (d), 126.3 (d), 127.3 (d), 128.3 (d), 131.9
(d), 134.8 (s), 136.4 (s), 159.3 (d), 171.4 (s) ppm. C15H13BrN2O
(317.2): calcd. C 56.80, H 4.13, N 8.83; found C 56.65, H 4.12, N
8.82. MS (CI): m/z  317 (100.0) [M  H], 319 (99.3) [M  H].
(2R)-2-{[(E)-(4-Bromophenyl)methylidene]amino}-2-phenylacet-
amide (17): Colourless prisms, 99% yield. M.p. 164.0165.3 °C. 1H
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NMR (300 MHz, CDCl3/[D6]DMSO): δ  4.68 (s, 1 H), 6.37 (br.
s, 1 H), 6.69 (br. s, 1 H), 6.987.21 (m, 5 H), 7.27 (d, J  8.4 Hz,
2 H), 7.43 (d, J  8.4 Hz, 2 H), 8.01 (s, 1 H) ppm. 13C NMR
(50 MHz, CDCl3/[D6]DMSO): δ  74.4 (d), 123.0 (s), 124.6 (d),
125.1 (d), 125.9 (d), 127.3 (d), 129.2 (d), 131.7 (s), 136.7 (s), 159.1
(d), 170.8 (s) ppm. C15H13BrN2O (317.2): calcd. C 56.80, H 4.13,
N 8.83; found C 56.70, H 4.22, N 8.86. MS (CI): m/z  317 (97.8)
[M  H], 319 (100.0) [M  H].
(2R)-2-{[(E)-(1,1-Biphenyl)-2-ylmethylidene]amino}-2-phenylethan-
amide (18): White solid, 85% yield. M.p. 152.5152.5 °C. 1H NMR
(300 MHz, CDCl3): δ  4.55 (s, 1 H), 6.27 (br. s, 1 H), 6.81 (br. s,
1 H), 6.977.92 (m, 14 H), 7.95 (d, J  6.2 Hz, 1 H), 8.02 (s, 1 H)
ppm. 13C NMR (50 MHz, CDCl3): δ  76.6 (d), 127.8 (d), 127.2
(d), 127.3 (d), 127.3 (d), 127.8 (d), 128.1 (d), 129.3 (d), 129.9 (s),
130.4 (d), 132.4 (s), 138.5 (s), 139.0 (s), 143.0 (s), 161.9 (d), 173.5
(s) ppm. C21H18N2O (314.4): calcd. C 80.23, H 5.77, N 8.91; found
C 80.02, H 5.71, N 8.91. MS (CI): m/z  315 [M  H].
(2R)-2-{[(E)-(1,1-Biphenyl)-3-ylmethylidene]amino}-2-phenylethan-
amide (19): White solid, 89% yield. M.p. 145.7146.4 °C. 1H NMR
(300 MHz, CDCl3): δ  4.99 (s, 1 H), 6.78 (br. s, 1 H), 7.04 (br. s,
1 H), 7.247.49 (m, 11 H), 7.59 (dd, J  6.6, J  1.1 Hz, 2 H),
7.66 (d, J  6.6 Hz, 1 H), 7.73 (d, J  6.6 Hz, 1 H), 7.99 (d, J 
1.1 Hz, 1 H), 8.31 (s, 1 H) ppm. 13C NMR (50 MHz, CDCl3): δ 
76.8 (d), 126.9 (d), 126.9 (d), 127.0 (d), 127.2 (d), 127.3 (d), 127.6
(d), 127.8 (d), 128.6 (d), 128.8 (d), 129.0 (d), 130.1 (d), 135.8 (s),
139.1 (s), 140.1 (s), 141.6 (s), 163.1 (d), 174.5 (s) ppm. C21H18N2O
(314.4): calcd. C 80.23, H 5.77, N 8.91; found C 80.29, H 5.82, N
8.84. MS (CI): m/z  315 [M  H].
(2R)-2-{[(E)-(1,1-Biphenyl)-4-ylmethylidene]amino}-2-phenylethan-
amide (20): White solid, 95% yield. M.p. 176.5177.0 °C. 1H NMR
(300 MHz, CDCl3): δ  4.96 (s, 1 H), 5.79 (br. s, 1 H), 7.00 (br. s,
1 H), 7.247.25 (m, 2 H), 7.31 (t, J  7.3 Hz, 2 H), 7.367.46 (m,
4 H), 7.57 (d, J  7.3 Hz, 2 H), 7.62 (d, J  8.1 Hz, 2 H), 7.82 (d,
J  8.1 Hz, 2 H), 8.30 (s, 1 H) ppm. 13C NMR (50 MHz, CDCl3):
δ  76.7 (d), 126.6 (d), 126.8 (d), 127.3 (d), 127.5 (d), 128.2 (d),
128.4 (d), 128.5 (d), 129.8 (s), 139.1 (s), 139.5 (s), 143.5 (s), 162.2
(d), 173.5 (s) ppm. C21H18N2O (314.4): calcd. C 80.23, H 5.77,
N 8.91; found C 80.35, H 5.84, N 8.88. MS (CI): m/z  315 [M
 H].
(2R)-2-{[(E)-(2-Nitrophenyl)methylidene]amino}-2-phenylacetamide
(21): Pale yellow needles, 97% yield. M.p. 165.0165.4 °C. 1H
NMR (300 MHz, CDCl3/[D6]DMSO): δ  4.90 (s, 1 H), 6.43 (br.
s, 1 H), 7.147.23 (m, 3 H), 7.31 (d, J  7.0 Hz, 2 H), 7.48 (dt,
J  7.5 Hz, 1 H), 7.56 (dt, J  7.5 Hz, 1 H), 7.83 (dd, J  7.5,
J  0.7 Hz, 1 H), 7.92 (dd, J  7.5, J  0.7 Hz, 1 H), 8.55 (s, 1
H), 6.73 (br. s, 1 H) ppm. 13C NMR (50 MHz, CDCl3/[D6]DMSO):
δ  76.9 (d), 123.9 (d), 126.9 (d), 127.7 (d), 127.7 (d), 128.4 (d),
129.5 (s), 129.7 (d), 131.2 (d), 133.0 (d), 138.3 (s), 148.5 (s), 158.7
(d), 172.8 (s) ppm. C15H13N3O3 (283.3): calcd. C 63.60, H 4.63, N
14.83; found C 63.55, H 4.57, N 14.78. MS (CI): m/z  284 [M
 H].
(2R)-2-{[(E)-(3-Nitrophenyl)methylidene]amino}-2-phenylacetamide
(22): Pale yellow plates, 98% yield. M.p. 174.0174.9 °C. 1H NMR
(300 MHz, CDCl3/[D6]DMSO): δ  4.73 (s, 1 H), 6.50 (br. s, 1 H),
6.72 (br. s, 1 H), 6.967.07 (m, 3 H), 7.167.21 (m, 2 H), 7.35 (t,
J  8.0 Hz, 1 H), 7.83 (dd, J  8.0, J  1.8 Hz, 1 H), 7.99 (dd,
J  8.0, J  1.1 Hz, 1 H), 8.13 (s, 1 H), 8.38 (s, 1 H) ppm. 13C
NMR (50 MHz, CDCl3/[D6]DMSO): δ  75.8 (d), 121.4 (d), 124.3
(d), 126.0 (d), 126.7 (d), 127.4 (d), 128.6 (d), 133.1 (d), 135.7 (s),
137.7 (s), 147.1 (s), 159.4 (d), 171.7 (s) ppm. C15H13N3O3 (283.3):
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calcd. C 63.60, H 4.63, N 14.83; found C 63.50, H 4.84, N 14.79.
MS (CI): m/z  284 [M  H].
(2R)-2-{[(E)-(4-Nitrophenyl)methylidene]amino}-2-phenylacetamide
(23): Pale yellow prisms, 92% yield. M.p. 168.2 °C. 1H NMR
(300 MHz, CDCl3): δ  5.07 (s, 1 H), 5.81 (br. s, 1 H), 6.86 (br. s,
1 H), 7.307.46 (m, 3 H), 7.98 (d, J  8.8 Hz, 2 H), 8.30 (d, J 
8.8 Hz, 2 H), 8.41 (s, 1 H) ppm. 13C NMR (50 MHz, CDCl3): δ 
77.3 (d), 124.0 (d), 127.2 (d), 128.4 (d), 129.0 (d), 129.2(d), 138.5
(s), 140.6 (s), 149.5 (s), 161.2 (d), 173.1 (s) ppm. C15H13N3O3
(283.3): calcd. C 63.60, H 4.63, N 14.83; found C 63.36, H 4.62, N
14.83. MS (CI): m/z  284 [M  H].
Typical Procedure for the Allylation of (R)-PGA Imines: A solution
of allylzinc bromide (1.5 equiv.) was prepared by adding allyl bro-
mide (38.5 mL, 438 mmol) to finely cut zinc wool (28.6 g,
438 mmol) in THF (250 mL). The solution of allylzinc bromide was
cooled to room temperature and 292 mmol of the imine in THF
(150 mL) was added at 0 °C. The reaction mixture was warmed to
room temperature and was then poured into water (500 mL). Ethyl
acetate (200 mL) was added and the mixture was stirred vigorously.
After filtration through Celite, the organic phase was separated and
the water layer was extracted with ethyl acetate (2  100 mL). The
combined organic phase was dried over sodium sulfate and the
ethyl acetate was evaporated to furnish the homoallylamine as a
colourless oil, which in some cases crystallised on standing. For
compounds 25 and 3135, the dr could be increased to 99:1 by
recrystallisation from acetone/hexane (1:20).
Typical Procedure for the Allylation of (R)-PGA Imines 211 and
1820 under Barbier Conditions: The imine (292 mmol) and zinc
wool (438 mmol, 28.6 g) were added successively to a flask fitted
with a cooler and charged with THF (250 mL). Allyl bromide
(438 mmol, 38.5 mL, 1.5 equiv.) in 50 mL of THF was added at 0
°C to the stirred mixture. The reaction mixture was allowed to
warm to room temperature. Workup was performed as described
above.
(2R)-2-{[(1R)-1-(2-Methylphenyl)-3-butenyl]amino}-2-phenylethan-
amide (25): Colourless plates, 93% yield, 99:1 dr. M.p. 104.3104.6
°C. 1H NMR (300 MHz, CDCl3): δ  2.25 (s, 3 H), 2.312.37 (m,
1 H), 3.89 (s, 1 H), 4.01 (d, J  6.2 Hz, 1 H), 5.025.11 (m, 2 H),
5.685.82 (m, 1 H), 6.12 (br. s, 1 H), 7.107.25 (m, 10 H) ppm.
13C NMR (50 MHz, CDCl3): δ  17.0 (q), 39.3 (t), 54.2 (d), 62.0
(d), 115.3 (t), 122.5 (d), 123.9 (d), 124.5 (d), 124.8 (d), 125.6 (d),
126.4 (d), 128.1 (d), 132.5 (d), 133.7 (s), 136.9 (s), 138.3 (s), 173.5
(s) ppm. C19H22N2O·1/2H2O: calcd. C 75.22, H 7.64, N 9.23; found
C 75.18, H 7.59, N 9.12. MS (CI): m/z  295 [M  H].
(2R)-2-{[(1R)-1-(3-Methylphenyl)-3-butenyl]amino}-2-phenylethan-
amide (26): Yellow oil, 99% yield, 99:1 dr. M.p. 79.080.3 °C.
1H NMR (300 MHz, CDCl3): δ  2.11 (br. s, 1 H), 2.30 (s, 3 H),
2.39 (d, J  7.0 Hz, 2 H), 3.65 (t, J  7.0 Hz, 1 H), 3.96 (s, 1 H),
5.035.10 (m, 2 H), 5.695.83 (m, 1 H), 6.967.06 (m  br. s, 3
H), 7.11 (br. s, 1 H), 7.167.29 (m, 7 H) ppm. 13C NMR (50 MHz,
CDCl3): δ  18.6 (q), 42.4 (t), 61.5 (d), 64.2 (d), 117.5 (t), 123.8
(d), 127.1 (d), 127.7 (d), 127.8 (d), 128.0 (d), 128.3 (d), 128.6 (d),
134.9 (d), 137.9 (s), 139.3 (s), 142.4 (s), 175.9 (s) ppm.
C19H22N2O·1/2H2O: calcd. C 75.22, H 7.64, N 9.23; found C 75.52,
H 7.45, N 9.35. MS (CI): m/z  295 [M  H].
(2R)-2-{[(1R)-1-(4-Methylphenyl)-3-butenyl]amino}-2-phenylethan-
amide (27): Colourless oil, which crystallised on standing, 97%
yield, 99:1 dr. M.p. 120.3121.4 °C. 1H NMR (300 MHz,
CDCl3): δ  2.04 (br. s, 1 H), 2.30 (s, 3 H), 2.38 (d, J  7.0 Hz, 2
H), 3.63 (t, J  7.0 Hz, 1 H), 3.95 (s, 1 H), 5.015.08 (m, 2 H),
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5.675.81 (m, 1 H), 6.12 (br. s, 1 H), 7.057.11 (m, 5 H),
7.167.24 (m, 5 H) ppm. 13C NMR (50 MHz, CDCl3): δ  18.6
(q), 40.0 (t), 59.0 (d), 61.9 (d), 115.2 (t), 124.4 (d), 124.8 (d), 125.6
(d), 126.3 (d), 126.8 (d), 132.6 (d), 134.6 (s), 136.8 (s), 136.9 (s),
173.7 (s) ppm. C19H22N2O (294.4): calcd. C 77.52, H 7.53, N 9.52;
found C 77.43, H 7.42, N 9.34. MS (CI): m/z  295 [M  H].
(2R)-2-{[(1R)-1-(2-Methoxyphenyl)-3-butenyl]amino}-2-phenyl-
ethanamide (28): Pale yellow solid, 98% yield, 99:1 dr. M.p.
63.163.8 °C. 1H NMR (300 MHz, CDCl3): δ  2.38 (d, J 
7.0 Hz, 2 H), 3.62 (t, J  7.0 Hz, 1 H), 3.76 (s, 3 H), 3.95 (s, 1 H),
5.005.07 (m, 2 H), 5.655.79 (m, 2 H), 5.97 (br. s, 1 H), 6.81 (d,
J  8.6 Hz, 2 H), 7.03 (br. s, 1 H), 7.07 (d, J  8.6 Hz, 2 H), 7.14
7.26 (m, 3 H) ppm. 13C NMR (50 MHz, CDCl3): δ  40.2 (t),
54.9 (q), 64.7 (d), 110.7 (d), 117.1 (t), 120.5 (d), 127.2 (d), 127.9
(d), 128.4 (d), 128.6 (d), 129.5 (s), 135.7 (d), 139.4 (s), 157.3 (s),
176.3 (s) ppm. C19H22N2O2·1/2H2O: calcd. C 71.45, H 7.26, N 8.77;
found C 71.43, H 6.88, N 8.76. MS (CI): m/z  311 [M  H].
(2R)-2-{[(1R)-1-(3-Methoxyphenyl)-3-butenyl]amino}-2-phenyl-
ethanamide (29): Pale yellow solid, 99% yield, 99:1 dr. M.p.
96.697.2 °C. 1H NMR (300 MHz, CDCl3): δ  2.08 (br. s, 1 H),
2.38 (d, J  7.0 Hz, 1 H), 3.65 (t, J  7.0 Hz, 1 H), 3.73 (s, 3 H),
3.97 (s, 1 H), 5.025.09 (m, 2 H), 5.685.81 (m, 1 H), 5.98 (br. s,
1 H), 6.706.77 (m, 3 H), 6.99 (br. s, 1 H), 7.177.26 (m, 6 H)
ppm. 13C NMR (50 MHz, CDCl3): δ  42.2 (t), 54.8 (q), 61.3 (d),
64.0(d), 112.4(d), 112.5 (d), 117.4 (t), 119.1 (d), 127.0 (d), 127.7 (d),
128.4 (d), 129.3 (d), 134.7 (d), 139.2 (s), 144.2 (s), 159.5 (s), 175.7 (s)
ppm. C19H22N2O2·1/2H2O: calcd. C 71.45, H 7.26, N 8.77; found C
71.45, H 6.90, N 8.79. MS (CI): m/z  311 [M  H].
(2R)-2-{[(1R)-1-(4-Methoxyphenyl)-3-butenyl]amino}-2-phenyl-
ethanamide (30): Pale yellow solid, 99% yield, 99:1 dr. M.p.
92.292.7 °C. 1H NMR (300 MHz, CDCl3): δ  2.38 (d, J 
7.0 Hz, 2 H), 3.62 (t, J  7.0 Hz, 1 H), 3.76 (s, 3 H), 3.95 (s, 1 H),
5.005.07 (m, 2 H), 5.655.79 (m, 2 H), 5.97 (br. s, 1 H), 6.81 (d,
J  8.6 Hz, 2 H), 7.03 (br. s, 1 H), 7.07 (d, J  8.6 Hz, 2 H), 7.14
7.26 (m, 3 H) ppm. 13C NMR (50 MHz, CDCl3): δ  42.1 (t),
55.0 (q), 60.9 (d), 63.9 (d), 113.7 (t), 117.4 (t), 127.1 (d), 127.8 (d),
128.0 (d), 128.6 (d), 134.0 (s), 134.7 (d), 138.9 (s), 158.6 (s), 176.0
(s) ppm. C19H22N2O2 (310.4): calcd. C 73.52, H 7.10, N 9.00; found
C 73.70, H 6.95, N 9.04. MS (CI): m/z  311 [M  H].
(2R)-2-{[(1R)-1-(2-Fluorophenyl)-3-butenyl]amino}-2-phenylethan-
amide (31): Pale yellow oil, which crystallises on standing, 99%
yield, 98:2 dr. 1H NMR (300 MHz, CDCl3): δ  2.20 (br. s, 1 H),
2.46 (dt, J  7.0 Hz, 2 H), 3.94 (s, 1 H), 3.99 (t, J  7.0 Hz, 1
H), 5.025.09 (m, 2 H), 5.695.83 (m, 1 H), 6.957.08 (m, 3 H),
7.137.28 (m, 8 H) ppm. 13C NMR (50 MHz, CDCl3): δ  40.9
(t), 56.3 (d), 64.6 (d), 115.6 (d, 2JC,F  22.0 Hz), 117.8 (t), 124.1
(d, 4JC,F  3.7 Hz), 127.02 (d), 127.9 (d), 128.3 (d, 3JC,F  4.9 Hz),
128.6 (d), 128.8 (d), 129.2 (s, 3JC,F  12.2 Hz), 134.6 (d), 139.1 (s),
160.91 (s, 1JC,F  245.4 Hz), 175.6 (s) ppm. C18H19FN2·1/2H2O:
calcd. C 70.34, H 6.56, N 9.11; found C 70.63, H 6.17, N 9.39. MS
(CI): m/z  299 [M  H].
(2R)-2-{[(1R)-1-(3-Fluorophenyl)-3-butenyl]amino}-2-phenylethan-
amide (32): Yellow oil, which crystallises on standing, 97% yield,
98:2 dr). 1H NMR (300 MHz, CDCl3): δ  2.20 (br. s, 1 H), 2.37
(d, J  7.0 Hz, 2 H), 3.68 (t, J  7.0 Hz, 1 H), 3.92 (s, 1 H),
5.015.07 (m, 2 H), 5.635.76 (m, 1 H), 6.71 (br. s, 1 H),
6.876.95 (m, 4 H), 7.157.26 (m, 6 H) ppm. 13C NMR (50 MHz,
CDCl3): δ  42.3 (t), 61.1 (d), 64.3 (d), 113.7 (d, 2JC,F  20.8 Hz),
114.2 (d, 2JC,F  22.0 Hz), 118.0 (t), 122.7 (d, 3JC,F  2.4 Hz),
127.1 (d), 128.1 (d), 128.8 (d), 130.0 (d, 3JC,F  8.6 Hz), 134.4 (d),
139.0 (s), 145.5 (s, 3JC,F  7.3 Hz), 163.0 (s, 1JC,F  246.6 Hz),
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175.6 (s) ppm. C18H19FN2 (282.4): calcd. C 72.46, H 6.42, N 9.39;
found C 72.19, H 6.30, N 9.51. MS (CI): m/z  299 [M  H].
(2R)-2-{[(1R)-1-(4-Fluorophenyl)-3-butenyl]amino}-2-phenylethan-
amide (33): Yellow oil, which crystallises on standing, 94% yield,
99:1 dr). 1H NMR (300 MHz, CDCl3): δ  2.14 (br. s, 2 H), 2.35
(t, J  7.0 Hz, 2 H), 3.65 (t, J  7.0 Hz, 1 H), 3.88 (s, 1 H),
4.995.05 (m, 2 H), 5.585.69 (m, 1 H), 6.44 (br. s, 1 H), 6.96 (t,
J  8.7 Hz, 2 H), 7.087.12 (m, 4 H), 7.187.22 (m, 4 H) ppm.
13C NMR (50 MHz, CDCl3): δ  42.3 (t), 61.3 (d), 64.3 (d), 115.5
(d, 2JC,F  13.8 Hz), 118.2 (t), 127.2 (d), 128.3 (d), 128.7 (d, 3JC,F 
5.7 Hz), 134.3 (d), 138.6 (s), 137.7 (s), 162.1 (s, 1JC,F  162.7 Hz),
175.8 (s) ppm. MS (CI): m/z  299 [M  H].
(2R)-2-{[(1R)-1-(2-Chlorophenyl)-3-butenyl]amino}-2-phenylethan-
amide (34): Pale yellow oil, which crystallises on standing, 98%
yield, 97:3 dr. M.p. 110.4111.0 °C. 1H NMR (300 MHz, CDCl3):
δ  2.322.52 (m  br. s, 3 H), 3.89 (s, 1 H), 4.25 (t, J  6.8 Hz,
1 H), 4.995.10 (m, 2 H), 5.685.82 (m, 1 H), 6.55 (br. s, 1 H),
7.04 (br. s, 1 H), 7.127.30 (m, 9 H) ppm. 13C NMR (50 MHz,
CDCl3): δ  40.7 (t), 58.2 (d), 64.5 (d), 118.1 (t), 127.0 (d), 127.2
(d), 127.7 (d), 128.1 (d), 128.4 (d), 128.8 (d), 129.9 (d), 133.8 (s),
134.4 (d), 138.9 (s), 139.4 (s), 175.6 (s) ppm. C18H19ClN2O (314.8):
calcd. C 68.67, H 6.08, N 8.90; found C 68.51, H 6.29, N 8.75. MS
(CI): m/z  315 [M  H]. MS (CI): m/z  315 (100.0) [M  H],
317 (35.8) [M  H].
(2R)-2-{[(1R)-1-(3-Chlorophenyl)-3-butenyl]amino}-2-phenylethan-
amide (35): (white plates, 83% yield, 98:2 dr. M.p. 39.240.3 °C.
1H NMR (200 MHz, CDCl3): δ  2.15 (br. s, 1 H), 2.33 (d, J 
6.8 Hz, 2 H), 3.63 (t, J  6.8 Hz, 1 H), 3.88 (s, 1 H), 4.975.05
(m, 2 H), 5.555.75 (m, 1 H), 6.54 (br. s, 1 H), 6.82 (br. s, 1 H),
6.977.24 (m, 8 H) ppm. 13C NMR (50 MHz, CDCl3): δ  42.4
(t), 61.3 (d), 64.3 (d), 118.2 (t), 125.2 (d), 127.1 (d), 127.6 (d), 128.2
(d), 128.8 (d), 129.8 (d), 134.2 (d), 134.4 (s), 138.9 (s), 144.8 (s),
175.5 (s) ppm. C18H19ClN2O (314.8): calcd. C 68.67, H 6.08, N
8.90; found C 68.32, H 6.16, N 8.76. MS (CI): m/z  315 (100.0)
[M  H], 317 (35.0) [M  H].
(2R)-2-{[(1R)-1-(4-Chlorophenyl)-3-butenyl]amino}-2-phenylethan-
amide (36): Yellow solid, 98% yield, 99:1 dr. M.p. 111.3112.0
°C. 1H NMR (300 MHz, CDCl3): δ  2.332.47 (m  br. s, 3 H),
3.71 (t, J  7.0 Hz, 1 H), 3.97 (s, 1 H), 5.585.72 (m, 2 H), 5.99
(br. s, 1 H), 6.80 (br. s, 1 H), 7.067.13 (m, 4 H), 7.217.24 (m, 5
H) ppm. 13C NMR (50 MHz, CDCl3): δ  42.2 (t), 61.3 (d), 64.3
(d), 118.4 (t), 127.2 (d), 128.4 (d), 128.5 (d), 128.8 (d), 129.0 (d),
133.3 (s), 124.1 (d), 138.5 (s), 175.5 (s), 140.5 (s) ppm.
C18H19ClN2O (314.8): calcd. C 68.67, H 6.08, N 8.90; found C
68.24, H 5.88, N 8.63. MS (CI): m/z  315 (100.0) [M  H], 317
(35.7) [M  H].
(2R)-2-{[(1R)-1-(2-Bromophenyl)-3-butenyl]amino}-2-phenylethan-
amide (37): Pale yellow oil, 98% yield, 99:1 dr). 1H NMR
(300 MHz, CDCl3): δ  2.242.50 (m  br. s, 3 H), 3.88 (s, 1 H),
4.24 (dd, J  8.1, J  5.1 Hz, 1 H), 5.055.15 (m, 2 H), 5.715.83
(m, 1 H), 6.45 (br. s, 1 H), 6.99 (br. s, 1 H), 7.06 (dt, J  7.5, J 
1.8 Hz, 1 H), 7.167.24 (m, 7 H), 7.49 (d, J  7.7 Hz, 1 H) ppm.
13C NMR (50 MHz, CDCl3): δ  38.6 (t), 57.7 (d), 62.0 (d), 115.7
(d), 121.9 (d), 124.8 (d), 125.2 (t), 125.5 (d), 125.6 (d), 126.3 (d),
126.3 (d), 130.7 (d), 132.1 (d), 136.8 (s), 138.9 (s), 173.1 (s) ppm.
C18H19BrN2O (359.3): calcd. C 60.18, H 5.33, N 7.80; found C
60.02, H 5.06, N 8.07. MS (CI): m/z  359 (39.8) [M  H], 361
(39.4) [M  H].
(2R)-2-{[(1R)-1-(3-Bromophenyl)-3-butenyl]amino}-2-phenylethan-
amide (38): Pale yellow oil, 99% yield, 99:1 dr). 1H NMR
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(300 MHz, CDCl3): δ  2.27 (br. s, 1 H), 2.41 (dt, J  7.0 Hz, 2
H), 3.66 (t, J  7.0 Hz, 1 H), 3.94 (s, 1 H), 5.025.13 (m, 2 H),
5.615.74 (m, 1 H), 6.26 (br. s, 1 H), 6.84 (br. s, 1 H), 7.087.30
(m, 8 H), 7.33 (dd, J  7.7, J  1.1 Hz, 1 H) ppm. 13C NMR
(50 MHz, CDCl3): δ  42.3 (t), 61.4 (d), 64.3 (d), 118.2 (t), 122.7
(s), 124.4 (d), 125.8 (d), 127.2 (d), 128.2 (d), 128.8 (d), 130.1 (d),
130.5 (d), 134.1 (d), 138.7 (s), 144.9 (s), 175.6 (s) ppm.
C18H19BrN2O (359.3): calcd. C 60.18, H 5.33, N 7.80; found C
59.84, H 5.21, N 7.67. MS (CI): m/z  359 (100.0) [M  H], 361
(99.3) [M  H].
(2R)-2-{[(1R)-1-(4-Bromophenyl)-3-butenyl]amino}-2-phenylethan-
amide (39): White solid, 95% yield, 99:1 dr. M.p. 115.6116.5 °C.
1H NMR (300 MHz, CDCl3): δ  2.24 (br. s, 1 H), 2.312.48 (m,
2 H), 3.68 (t, J  6.8 Hz, 1 H), 3.93 (s, 1 H), 5.015.07 (m, 2 H),
5.605.73 (m, 1 H), 6.30 (br. s, 1 H), 6.84 (br. s, 1 H), 7.03 (d, J 
8.2 Hz, 2 H), 7.117.14 (m, 2 H), 7.227.24 (m, 3 H), 7.39 (d, J 
8.2 Hz, 2 H) ppm. 13C NMR (50 MHz, CDCl3): δ  42.3 (t), 61.3
(d), 64.3 (d), 118.3 (t), 121.2 (s), 127.2 (d), 128.3 (d), 128.85 (d),
128.93 (d), 131.7 (d), 134.2 (d), 138.7 (s), 141.3 (s), 175.6 (s) ppm.
C18H19BrN2O (359.3): calcd. C 60.18, H 5.33, N 7.80; found C
59.75, H 5.37, N 7.72. MS (CI): m/z  359 (100.0) [M  H], 361
(99.8) [M  H].
(2R)-2-{[(1R)-1-(1,1-Biphenyl)-2-yl-3-butenyl]amino}-2-phenyl-
ethanamide (40): Pale yellow solid, 89% yield, 99:1 dr. 1H NMR
(500 MHz, CDCl3): δ  2.16 (br. s, 1 H), 2.282.41 (m, 2 H), 3.99
(dt, J  5.4, J  3.0 Hz, 1 H), 4.01 (s, 1 H), 4.995.04 (m, 2 H),
5.645.73 (m, 1 H), 5.78 (br. s, 1 H), 7.04 (br. s, 1 H), 7.237.25
(m, 5 H), 7.297.41 (m, 9 H) ppm. 13C NMR (50 MHz, CDCl3):
δ  56.9 (t), 64.6 (d), 125.3 (d), 126.7 (d), 127.0 (d), 127.2 (d), 127.8
(t), 128.0 (d), 128.1 (d), 128.7 (d), 129.2 (d), 130.1 (d), 135.0 (d),
139.4 (s), 140.2 (s), 140.7 (s), 142.5 (s), 175.3 (s) ppm. MS (CI):
m/z  357 [M  H].
(2R)-2-{[(1R)-1-(1,1-Biphenyl)-3-yl-3-butenyl]amino}-2-phenyl-
ethanamide (41): Yellow oil, 85% yield, 99:1 dr. 1H NMR
(300 MHz, CDCl3): δ  2.37 (br. s, 1 H), 2.50 (t, J  6.6 Hz, 2 H),
3.83 (t, J  6.6 Hz, 1 H), 4.08 (s, 1 H), 5.03 5.16 (m, 2 H),
5.745.87 (m, 1 H), 7.197.24 (m, 6 H), 7.337.45 (m, 5 H), 7.51
(d, J  7.7 Hz, 1 H), 7.57 (dd, J  7.7, J  1.1 Hz, 2 H), 7.00 (br.
s, 1 H), 7.08 (br. s, 1 H) ppm. 13C NMR (50 MHz, CDCl3): δ 
42.3 (t), 61.6 (d), 64.2 (d), 117.7 (t), 125.7 (d), 125.8 (d), 126.0 (d),
126.9 (d), 127.1 (d), 127.2 (d), 127.9 (d), 128.5 (d), 128.6 (d), 128.8
(d), 134.6 (d), 139.1 (s), 140.6 (s), 141.2 (s), 143.0 (s), 175.9 (s) ppm.
MS (CI): m/z  357 [M  H].
(2R)-2-{[(1R)-1-(1,1-Biphenyl)-4-yl-3-butenyl]amino}-2-phenyl-
ethanamide (42): Pale green oil, 99% yield, 99:1 dr. 1H NMR
(300 MHz, CDCl3): δ  2.27 (br. s, 1 H), 2.45 (t, J  6.6 Hz, 2 H),
3.75 (t, J  6.6 Hz, 1 H), 4.02 (s, 1 H), 5.045.84 (m, 2 H), 5.73
5.84 (m, 1 H), 6.75 (br. s, 1 H), 7.04 (br. s, 1 H), 7.227.33 (m,
8 H), 7.40 (t, J  7.3 Hz, 2 H), 7.52 (d, J  8.1 Hz, 2 H), 7.56 (d,
J  7.3 Hz, 2 H) ppm. 13C NMR (50 MHz, CDCl3): δ  42.4 (t),
61.2 (d), 64.5 (d), 117.7 (t), 126.8 (d), 127.1 (d), 127.4 (d), 127.9
(d), 128.6 (d), 134.7 (d), 139.2 (s), 140.1 (s), 140.5 (s), 141.5 (s),
175.7 (s) ppm. MS (CI): m/z  357 [M  H].
(2R)-2-{[(1R)-1-(2-Nitrophenyl)-3-butenyl]amino}-2-phenylethan-
amide (43): Orange oil, 99% yield,99:1 dr. 1H NMR (300 MHz,
CDCl3/[D6]DMSO): δ  2.492.57 (m, 1 H), 2.352.45 (m, 1 H),
2.96 (br. s, 1 H), 3.93 (s, 1 H), 4.35 (dd, J  5.1, J  2.9 Hz, 1 H),
5.065.12 (m, 2 H), 5.755.89 (m, 1 H), 7.00 (br. s, 1 H),
7.197.28 (m br. s, 5 H), 7.397.44 (m, 2 H), 7.60 (t, J  7.3 Hz,
1 H), 7.78 (d, J  8.1 Hz, 1 H), 7.86 (d, J  7.3 Hz, 1 H) ppm.
13C NMR (50 MHz, CDCl3/[D6]DMSO): δ  42.0 (t), 54.9 (d),
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63.1 (d), 117.8 (t), 123.7 (d), 126.9 (d), 127.2 (d), 128.1 (d), 128.8
(d), 133.0 (d), 134.7 (d), 137.9 (s), 140.0 (s), 149.9 (s), 173.8 (s)
ppm. C18H19N3O3 (325.4): calcd. C 66.45, H 5.89, N 12.91; found
C 66.06, H 5.97, N 12.72. MS (CI): m/z  326 [M  H].
(2R)-2-{[(1R)-1-(3-Nitrophenyl)-3-butenyl]amino}-2-phenylethan-
amide (44): Orange oil, which crystallises on standing, 96% yield,
99:1 dr. 1H NMR (200 MHz, CDCl3): δ  2.462.62 (m  br.
s, 3 H), 3.92 (t, J  6.8 Hz, 1 H), 4.09 (s, 1 H), 5.065.13 (m, 2
H), 5.615.82 (m, 1 H), 6.02 (br. s, 1 H), 6.57 (br. s, 1 H),
7.157.27 (m, 5 H), 7.427.57 (m, 2 H), 8.068.11 (m, 2 H) ppm.
13C NMR (50 MHz, CDCl3): δ  42.3 (t), 61.4 (d), 64.7(d), 119.0
(t), 122.1 (d), 122.5 (d), 127.3 (d), 128.5 (d), 129.0 (d), 129.5 (d),
133.4 (d), 133.6 (d), 138.3 (s), 144.8 (s), 148.4 (s), 175.0 (s) ppm.
C18H19N3O3 (325.4): calcd. C 66.45, H 5.89, N 12.91; found C
66.21, H 5.80, N 12.82. MS (CI): m/z  326 [M  H].
(2R)-2-{[(1R)-1-(4-Nitrophenyl)-3-butenyl]amino}-2-phenylethan-
amide (45): Orange oil, 93% yield, 99:1 dr. 1H NMR (300 MHz,
CDCl3): δ  2.382.47 (m, 1 H), 2.542.63 (m, 1 H), 2.75 (br. s,
1 H), 3.93 (t, J  6.2 Hz, 1 H), 4.07 (s, 1 H), 4.975.02 (m, 2 H),
5.495.63 (m, 1 H), 6.58 (br. s, 1 H), 6.77 (br. s, 1 H), 7.077.18
(m, 5 H), 7.29 (d, J  8.6 Hz, 2 H), 8.03 (d, J  8.6 Hz, 2 H) ppm.
13C NMR (50 MHz, CDCl3): δ  41.8 (t), 61.7 (d), 64.3 (d), 119.1
(t), 123.7 (d), 124.3 (d), 127.4 (d), 128.8 (d), 129.1 (d), 133.0 (d),
137.4 (s), 147.3 (s), 149.1 (s), 176.3 (s) ppm. C18H19N3O3 (325.4):
calcd. C 66.45, H 5.89, N 12.91; found C 66.32, H 5.90, N 12.88.
MS (CI): m/z  326 [M  H].
Typical Procedure for the Catalytic Hydrogenation of (R)-PGA
Homoallylamines 2433 and 40: The PGA allylamine (15.0 mmol)
was dissolved in isopropyl alcohol (75 mL). Water (75 mL), acetic
acid (100 mL), and PdC (10%) (0.6 gram, cat) were added suc-
cessively. After two vacuum/H2 cycles to remove air from the reac-
tion flask, the stirred mixture of the substrate was hydrogenated at
ambient pressure of H2 and room temperature for 5 days. After
filtration, the isopropyl alcohol was evaporated off under reduced
pressure. The residue was diluted with water (50 mL) and while
acidic, the reaction mixture was washed once with diethyl ether to
remove any by-products. The aqueous phase was brought to pH 10
with 10% NaOH and was extracted with CH2Cl2 (3  40 mL). The
combined organic phase was washed with brine, dried over sodium
sulfate and filtered. After evaporation of the CH2Cl2, pentane was
added to the residue. Filtration through a glass filter yielded crys-
talline phenyl acetamide. Evaporation of the pentane yielded the
primary substituted (R)-phenylbutylamine as an oil.
(1R)-1-Butyl-1-(2-methylphenyl)amine (48): Yellow oil, 95% yield.
[α]D25  32.8 (c  2.08, CHCl3). 1H NMR (300 MHz, CDCl3):
δ  0.89 (t, J  7.3 Hz, 3 H), 1.201.44 (m, 2 H), 1.52 (br. s, 2
H), 1.461.63 (m, 2 H), 2.31 (s, 3 H), 4.14 (t, J  6.6 Hz, 1 H),
7.09 (d, J  4.4 Hz, 2 H), 7.147.22 (m, 1 H), 7.37 (d, J  7.3 Hz,
1 H) ppm. 13C NMR (50 MHz, CDCl3): δ  13.8 (q), 19.6 (t), 21.2
(q), 41.6 (t), 55.7 (d), 123.1 (d), 126.8 (d), 127.3 (d), 128.0 (d), 137.7
(s), 146.5 (s) ppm. C11H17N (163.3): calcd. C 80.93, H 10.50, N
8.58; found C 80.69, H 10.62, N 8.46. MS (CI): m/z  164 [M
 H].
(1R)-1-Butyl-1-(3-methylphenyl)amine (49): Yellow oil, 92% yield.
[α]D25  13.59 (c  1.13, CHCl3). 1H NMR (300 MHz, CDCl3):
δ  0.88 (t, J  7.3 Hz, 3 H), 1.181.38 (m, 2 H), 1.44 (br. s, 2
H), 1.561.64 (m, 2 H), 2.31 (s, 3 H), 3.80 (t, J  7.0 Hz, 1 H),
7.00 (d, J  7.5 Hz, 1 H), 7.05 (d, J  7.5 Hz, 1 H), 7.09 (s, 1 H),
7.17 (t, J  7.5 Hz, 1 H) ppm. 13C NMR (50 MHz, CDCl3): δ 
13.8 (q), 19.5 (t), 21.2 (q), 55.7 (t), 123.1 (d), 126.7 (d), 127.3 (d),
128.0 (d), 137.6 (s), 146.6 (s) ppm. MS (CI): m/z  164 [M  H].
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(1R)-1-Butyl-1-(4-methylphenyl)amine (50): Yellow oil, which crys-
tallised on standing, 91% yield. M.p. 55.056.5 °C. [α]D25  19.34
(c  2.23, CHCl3). 1H NMR (300 MHz, CDCl3): δ  0.85 (t, J 
7.3 Hz, 3 H), 1.131.34 (m, 2 H), 1.751.50 (m, 2 H), 1.70 (br. s,
2 H), 2.26 (s, 3 H), 3.77 (t, J  7.0 Hz, 1 H), 7.06 (d, J  8.1 Hz,
2 H), 7.13 (d, J  8.1 Hz, 2 H) ppm. 13C NMR (50 MHz, CDCl3):
δ  13.6 (q), 19.3 (t), 20.5 (q), 41.4 (t), 55.2 (d), 125.7 (d), 128.6
(d), 135.7 (s), 143.2 (s) ppm. MS (CI): m/z  164 [M  H].
(1R)-1-Butyl-1-(2-methoxyphenyl)amine (51): Colourless oil, which
crystallises on standing, 87% yield. M.p. 56.857.6 °C. [α]D25 
4.49 (c  3.45, CHCl3). 1H NMR (300 MHz, CDCl3): δ  0.88
(t, J  7.3 Hz, 3 H), 1.151.39 (m, 2 H), 1.531.90 (m  br. s, 3
H), 3.76 (s, 3 H), 4.10 (t, J  7.0 Hz, 1 H), 6.80 (d, J  8.1 Hz, 1
H), 6.87 (t, J  7.3 Hz, 1 H), 7.15 (dt, J  8.1, J  1.8 Hz, 1 H),
7.21 (dd, J  7.3, J  1.8 Hz, 1 H), 13C NMR (50 MHz, CDCl3):
δ  14.0 (q), 19.9 (t), 39.7 (t), 50.5 (d), 55.1 (q), 110.4 (d), 120.5
(d), 126.6 (d), 127.4 (d), 134.7 (s), 156.8 (s) ppm. C11H17NO
(179.3): calcd. C 73.70, H 9.56, N 7.81; found C 73.40, H 9.96, N
7.54. MS (CI): m/z  180 [M  H].
(1R)-1-Butyl-1-(3-methoxyphenyl)amine (52): Pale yellow oil, 89%
yield. [α]D25  16.4 (c  3.68, CHCl3). 1H NMR (300 MHz,
CDCl3): δ  0.80 (t, J  7.3 Hz, 3 H), 1.121.29 (m, 2 H), 1.39
(br. s, 2 H), 1.491.56 (m, 2 H), 3.68 (s, 3 H), 3.74 (t, J  7.0 Hz,
1 H), 6.66 (dd, J  8.1, J  1.8 Hz, 1 H), 6.776.79 (m, 2 H), 7.12
(t, J  8.1 Hz, 1 H) ppm. 13C NMR (50 MHz, CDCl3): δ  13.7
(q), 19.4 (t), 41.5 (t), 54.7 (d), 55.7 (q), 111.6 (d), 111.7 (d), 118.3
(d), 129.0 (d), 148.3 (s), 159.4 (s) ppm. C11H17NO (179.3): calcd.
C 73.70, H 9.56, N 7.81; found C 73.59, H 9.54, N 7.81. MS (CI):
m/z  180 [M  H].
(1R)-1-Butyl-1-(4-methoxyphenyl)amine (53): Yellow oil, 89% yield.
[α]D25  12.57 (c  7.39, CHCl3). 1H NMR (300 MHz, CDCl3):
δ  0.87 (t, J  7.1 Hz, 3 H), 1.141.36 (m, 2 H), 1.44 (br. s, 2
H), 1.501.69 (m, 2 H), 3.76 (s, 3 H), 3.82 (t, J  6.8 Hz, 1 H),
6.84 (d, J  8.8 Hz, 2 H), 7.20 (d, J  8.8 Hz, 2 H) ppm. 13C
NMR (50 MHz, CDCl3): δ  13.9 (q), 19.6 (t), 41.8 (t), 55.0 (q),
55.2 (d), 113.5 (d), 127.1 (d), 138.8 (s), 158.3 (s) ppm. C11H17NO
(179.3): calcd. C 73.70, H 9.56, N 7.81; found C 73.58, H 9.47, N
7.67. MS (CI): m/z  180 [M  H].
(1R)-1-Butyl-1-(2-fluorophenyl)amine (54): Pale yellow oil, 58%
yield. [α]D27  9.39 (c  3.21, CHCl3). 1H NMR (300 MHz,
CDCl3): δ  0.82 (t, J  7.3 Hz, 3 H), 1.111.36 (m, 2 H), 1.45
(br. s, 2 H), 1.561.63 (m, 2 H), 4.10 (t, J  7.0 Hz, 1 H),
6.876.93 (m, 1 H), 7.04 (dt, J  7.32, J  1.1 Hz, 1 H), 6.987.13
(m, 1 H), 7.27 (dt, J  7.3, J  1.8 Hz, 1 H) ppm. 13C NMR
(50 MHz, CDCl3): δ  13.7 (q), 19.5 (t), 40.4 (t), 49.5 (d), 115.1
(d, 2JC,F  23.2 Hz), 123.9 (d, 4JC,F  3.7 Hz), 127.3 (d, 3JC,F 
4.9 Hz), 127.8 (d, 3JC,F  8.5 Hz), 133.4 (s, 2JC,F  14.7 Hz), 160.3
(s, 1JC,F  294.2 Hz) ppm. MS (CI): m/z  168 [M  H].
(1R)-1-Butyl-1-(3-fluorophenyl)amine (55): Pale yellow oil, 79%
yield. [α]D25  16.6 (c  7.21, CHCl3). 1H NMR (300 MHz,
CDCl3): δ  0.80 (t, J  7.1 Hz, 3 H), 1.061.32 (m, 2 H), 1.41
(br. s, 2 H), 1.441.57 (m, 2 H), 3.77 (t, J  7.0 Hz, 1 H), 6.79
(dt, J  8.1 Hz, 1 H), 6.95 (dt, J  8.3 Hz, 2 H), 7.15 (dd, J 
13.9, J  8.1 Hz, 1 H) ppm. 13C NMR (50 MHz, CDCl3): δ  11.4
(q), 17.0 (t), 39.2 (t), 53.1 (d), 110.6 (d, 2JC,F  22.97 Hz), 111.0
(d, 2JC,F  22.0 Hz), 119.5 (d, 3JC,F  2.4 Hz), 127.2 (d, 4JC,F 
7.3 Hz), 147.1 (s, 3JC,F  6.1 Hz), 160.5 (s, 1JC,F  245.4 Hz) ppm.
MS (CI): m/z  168 [M  H].
(1R)-1-Butyl-1-(4-fluorophenyl)amine (56): Pale yellow oil, 70%
yield. 1H NMR (300 MHz, CDCl3): δ  0.83 (t, J  7.3 Hz, 3 H),
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1.081.32 (m, 2 H), 1.50 (br. s, 2 H), 1.451.61 (m, 2 H), 3.81 (t,
J  7.0 Hz, 1 H), 6.92 (dd, J  8.8, 2JH,F  8.4 Hz, 2 H), 7.20 (dd,
J  5.5, 3JH,F  8.4 Hz, 2 H) ppm. 13C NMR (50 MHz, CDCl3):
δ  13.8 (q), 19.5 (t), 41.7 (t), 55.1 (d), 114.9 (d, 2JC,F  21.0 Hz),
127.6 (d, 3JC,F  7.6 Hz), 142.2 (s, 4JC,F  3.6 Hz), 161.5 (s, 1JC,F 
244.5 Hz) ppm. MS (CI): m/z  168 [M  H].
(1R)-1-[(1,1-Biphenyl)-2-yl]butylamine (57): Yellow oil, 87% yield.
[α]D25  16.17 (c  2.18, CHCl3). 1H NMR (300 MHz, CDCl3):
δ  0.73 (t, J  7.3 Hz, 3 H), 0.981.28 (m, 2 H), 1.47 (br. s, 2
H), 1.521.63 (m, 2 H), 4.00 (t, J  7.0 Hz, 1 H), 7.16 (d, J 
7.7 Hz, 1 H), 7.207.33 (m, 5 H), 7.36 (d, J  7.0 Hz, 2 H), 7.52
(d, J  7.7 Hz, 1 H) ppm. 13C NMR (50 MHz, CDCl3): δ  13.8
(q), 19.6 (t), 41.5 (t), 50.7 (d), 125.5 (d), 126.2 (d), 126.8 (d), 127.8
(d), 127.9 (d), 129.2 (d), 129.8 (d), 141.2 (s), 141.4 (s), 144.1 (s)
ppm. MS (CI): m/z  226 [M  H].
Typical Procedure for the Non-Reductive Removal of the Chiral
Auxiliary:[12a] DMF (48.8, mmol, 3.79 mL) was added to CH2Cl2
(450 mL) cooled in an ice bath. Oxalyl chloride (48.8 mmol,
4.60 mL) was then added dropwise. After the formation of gas (CO
and CO2) had ceased, a solution of the (R,R)-PGA allylamine
(32.5 mmol) in 100 mL of CH2Cl2 was added all at once. Triethyl-
amine (32.5 mmol, 4.60 mL) was added dropwise over 30 minutes
and the reaction was stirred at room temperature for 30 minutes.
H2O (450 mL) was added and the organic phase was separated.
The organic layer was dried over Na2SO4 and filtered. After evap-
oration of the solvent, the oily material was dissolved in absolute
ethanol (150 mL). After the addition of K2CO3 (2 equivalents;
64.9 mmol; 8.97 gram), the reaction mixture was refluxed for two
hours. After cooling the reaction mixture to room temperature, the
solvent was evaporated. The residue was mixed with water
(100 mL) and CH2Cl2 (100 mL). The organic phase was separated,
dried over Na2SO4 and filtered. After removal of the solvent, the
crude product was dissolved in a 50% aqueous THF (350 mL), 3
equivalents of NH2OH·HCl (6.80 g, 97.4 mmol) were added and
the reaction mixture was stirred overnight at ambient temperature.
The THF was evaporated under reduced pressure and the residue
was brought to pH 1 with aqueous HCl (30%). The aqueous phase
was washed once with CH2Cl2 to remove the by-products. The
aqueous phase was adjusted to pH 10 with aqueous NaOH (33%)
and extracted with CH2Cl2. After drying over Na2SO4, the solvent
was evaporated to furnish the (R)-arylbutenylamine as an oily ma-
terial. If necessary, the 1-aryl-3-butenylamines can be purified by
kugelrohr distillation.
(1R)-1-Butyl-3-butenyl-1-(2-chlorophenyl)amine (66): Yellow oil,
75% yield, 99:1 er. [α]D25  61.0 (c  3.44, CHCl3). 1H NMR
(300 MHz, CDCl3): δ  1.48 (br. s, 2 H), 2.172.27 (m, 1 H),
2.422.52 (m, 1 H), 4.39 (dd, J  4.6, J  8.2 Hz, 1 H), 4.975.09
(m, 2 H), 5.635.79 (m, 1 H), 7.08 (dt, J  7.7 J  1.1 Hz, 1 H),
7.17 (d, J  7.7 Hz, 1 H), 7.24 (t, J  8.8 Hz, 1 H), 7.44 (dd, J 
7.7, J  1.1 Hz, 1 H) ppm. 13C NMR (50 MHz, CDCl3): δ  41.9
(t), 51.0 (d), 117.7 (t), 126.8 (d), 127.0 (d), 127.7 (d), 129.3 (d),
132.6 (s), 135.0 (d), 142.7 (s) ppm. MS (CI): m/z  182 (100.0) [M
 H], 184 (32.3) [M  H].
(1R)-1-Butyl-3-butenyl-1-(3-chlorophenyl)amine (67): Yellow oil,
58% yield, 99:1 er. [α]D25  31.5 (c  2.98, CHCl3). 1H NMR
(300 MHz, CDCl3): δ  1.55 (br. s, 2 H), 2.212.42 (m, 2 H), 3.91
(dd, J  7.9, J  5.1 Hz, 1 H), 5.025.08 (m, 2 H), 5.595.73 (m,
1 H), 7.127.22 (m, 3 H), 7.29 (s, 1 H) ppm. 13C NMR (50 MHz,
CDCl3): δ  43.9 (t), 54.7 (d), 117.9 (d), 124.4 (d), 126.4 (d), 127.0
(d), 129.5 (d), 134.0 (s), 134.7 (d), 147.8 (s) ppm. MS (CI): m/z 
182 (100.0) [M  H], 184 (33.1) [M  H].
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(1R)-1-Butyl-3-butenyl-1-(4-chlorophenyl)amine (68): Orange oil,
70% yield, 99:1 er. [α]D25  30.0 (c  2.99, CHCl3). 1H NMR
(300 MHz, CDCl3): δ  1.59 (br. s, 2 H), 2.182.37 (m, 2 H), 3.88
(dd, J  7.7, J  5.5 Hz, 1 H), 4.985.05 (m, 2 H), 5.565.70 (m,
1 H), 7.167.27 (m, 4 H) ppm. 13C NMR (50 MHz, CDCl3): δ 
43.9 (t), 54.5 (d), 117.8 (t), 127.6 (d), 128.2 (d), 132.3 (s), 134.76
(d), 144.00 (s) ppm. MS (CI): m/z  182 (100.0) [M  H], 184
(34.3) [M  H].
(1R)-1-(2-Bromophenyl)-3-butenylamine (69): Red oil, 65% yield,
99:1 er. [α]D25  39.3 (c  2.40, CHCl3). 1H NMR (300 MHz,
CDCl3): δ  1.49 (br. s, 2 H), 2.132.23 (m, 1 H), 2.422.50 (m,
1 H), 4.34 (dd, J  8.4, J  4.4 Hz, 1 H), 4.975.09 (m, 2 H),
5.655.70 (m, 1 H), 7.00 (t, J  7.7 Hz, 1 H), 7.22 (t, J  7.7 Hz,
1 H), 7.44 (d, J  8.1 Hz, 2 H) ppm. 13C NMR (50 MHz, CDCl3):
δ  42.0 (t), 53.4 (d), 117.7 (t), 123.1 (s), 127.2 (d), 127.4 (d), 128.1
(d), 132.6 (d), 134.9 (d), 144.2 (s) ppm. MS (CI): m/z  226 (76.3)
[M  H], 228 (74.0) [M  H].
(1R)-1-(3-Bromophenyl)-3-butenylamine (70): Yellow oil, 51% yield,
99:1 er. [α]D25  29.9 (c  2.84, CHCl3). 1H NMR (300 MHz,
CDCl3): δ  1.87 (br. s, 2 H), 2.122.42 (m, 2 H), 3.90 (dd, J 
7.7, J  5.5 Hz, 1 H), 4.975.08 (m, 2 H), 5.595.72 (m, 1 H),
7.12 (t, J  7.7 Hz, 1 H), 7.20 (d, J  7.7 Hz, 1 H), 7.30 (d, J 
7.7 Hz, 1 H), 7.44 (s, 1 H) ppm. 13C NMR (50 MHz, CDCl3): δ 
43.8 (t), 54.6 (d), 117.8 (t), 124.8 (s), 129.19 (d), 129.68 (d), 134.62
(d), 148.00 (s) ppm. MS (CI): m/z  226 (100.0) [M  H], 228
(97.4) [M  H].
(1R)-1-(4-Bromophenyl)-3-butenylamine (71): Pale yellow oil, 48%
yield, 99:1 er. 1H NMR (300 MHz, CDCl3): δ  1.61 (br. s, 2 H),
2.122.41 (m, 2 H), 3.92 (t, J  6.4 Hz, 1 H), 5.025.08 (m, 2 H),
5.595.73 (m, 1 H), 7.17 (d, J  8.4 Hz, 2 H), 7.39 (d, J  8.4 Hz,
2 H) ppm. 13C NMR (50 MHz, CDCl3): δ  44.1 (t), 54.8 (d),
118.0 (t), 120.6 (s), 128.1 (d), 131.4 (d), 134.9 (d), 151.0 (s) ppm.
MS (CI): m/z  226 (100.0) [M  H], 228 (98.0) [M  H].
(1R)-1-[(1,1-Biphenyl)-3-yl]-3-butenylamine (72): Yellow oil, 45%
yield. [α]D25  12.5 (c  0.98, CHCl3). 1H NMR (300 MHz,
CDCl3): δ  1.96 (br. s, 1 H), 2.282.47 (m, 2 H), 3.99 (t, J 
6.4 Hz, 1 H), 5.015.20 (m, 2 H), 5.655.78 (m, 1 H), 7.247.42
(m, 6 H), 7.527.55 (m, 3 H) ppm. 13C NMR (50 MHz, CDCl3):
δ  44.0 (t), 55.2 (d), 117.5 (t), 125.0 (d), 125.1 (d), 125.6 (d), 126.9
(d), 127.0 (d), 128.5 (d), 128.6 (d), 135.2 (d), 141.0 (s), 141.1 (s),
146.1 (s) ppm. MS (CI): m/z  224 [M  H].
(1R)-1-[(1,1-Biphenyl)-4-yl]-3-butenylamine (73): Yellow oil, 49%
yield. 1H NMR (300 MHz, CDCl3): δ  1.85 (br. s, 2 H),
2.282.51 (m, 1 H), 2.813.00 (m, 1 H), 4.00 (t, J  5.9 Hz, 1 H),
4.985.13 (m, 2 H), 5.505.80 (m, 1 H), 7.097.46 (m, 7 H), 7.53
(t, J  7.3 Hz, 2 H) ppm. 13C NMR (50 MHz, CDCl3): δ  40.0
(t), 55.1 (d), 117.8 (t), 126.9 (d), 127.0 (d), 128.1 (d), 128.7 (d),
130.1 (d), 135.9 (d), 131.1 (s), 139.9 (s), 140.9 (s) ppm. MS (CI):
m/z  224 [M  H].
Typical Procedure for the Catalytic Hydrogenation of Phenylaceta-
mide-Protected Homoallylamines (R)-6673: Homoallylamine
(15.0 mmol) was dissolved in 100 mL of EtOAc, and PtC (5%)
(0.6 gram, cat) was added. After two vacuum/H2 cycles to remove
air from the reaction flask, the stirred mixture of the substrate was
hydrogenated at ambient pressure of H2 and room temperature for
1 hour. After filtration, the EtOAc was evaporated under reduced
pressure.
(1R)-1-Butyl-1-(2-chlorophenyl)amine (74): Green oil, 91% yield,
99:1 er. 1H NMR (300 MHz, CDCl3): δ  0.87 (t, J  7.3 Hz, 3
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H), 1.211.43 (m, 2 H), 1.571.72 (m, 2 H), 1.90 (br. s, 2 H), 4.34
(t, J  6.6 Hz, 1 H), 7.09 (t, J  7.7 Hz, 1 H), 7.19 (d, J  7.7 Hz,
1 H), 7.25 (t, J  8.2 Hz, 1 H), 7.41 (d, J  7.3 Hz, 1 H) ppm. 13C
NMR (50 MHz, CDCl3): δ  13.7 (q), 19.32 (t), 39.9 (t), 51.4 (d),
126.8 (d), 127.5 (d), 129.2 (d), 132.6 (s), 143.5 (s) ppm. MS (CI):
m/z  184 (100.0) [M  H], 186 (33.1) [M  H].
(1R)-1-Butyl-1-(3-chlorophenyl)amine (75): Orange oil, 99% yield,
99:1 er. [α]D25  24.2 (c  3.14, CHCl3). 1H NMR (300 MHz,
CDCl3): δ  0.83 (t, J  7.3 Hz, 3 H), 1.091.33 (m, 2 H),
1.461.61 (m, 2 H), 1.65 (br. s, 2 H), 3.79 (t, J  6.6 Hz, 1 H),
7.097.20 (m, 3 H), 7.24 (s, 1 H) ppm. 13C NMR (50 MHz,
CDCl3): δ  13.9 (q), 19.5 (t), 41.6 (t), 55.5 (d), 124.5 (d), 126.4
(d), 126.8 (d), 129.5 (d), 134.1 (s), 148.8 (s) ppm. MS (CI): m/z 
184 (100.0) [M  H], 186 (33.5) [M  H].
(1R)-1-Butyl-1-(4-chlorophenyl)amine (76): Yellow oil, 99% yield,
99:1 er. [α]D25  11.2 (c  6.35, CHCl3). 1H NMR (300 MHz,
CDCl3): δ  0.83 (t, J  7.1 Hz, 3 H), 1.151.32 (m, 2 H),
1.491.64 (m, 2 H), 2.11 (br. s, 2 H), 3.83 (t, J  6.8 Hz, 1 H),
7.19 (d, J  8.4 Hz, 2 H), 7.23 (d, J  8.4 Hz, 2 H) ppm. 13C
NMR (50 MHz, CDCl3): δ  13.7 (q), 19.3 (t), 41.4 (t), 55.1 (d),
127.5 (d), 128.1 (d), 132.0 (s), 144.8 (s) ppm. MS (CI): m/z  184
(100.0) [M  H], 186 (32.7) [M  H].
(1R)-1-(2-Bromophenyl)-1-butylamine (77): Dark green oil, 99%
yield, 99:1 er. [α]D25  17.9 (c  3.33, CHCl3). 1H NMR
(300 MHz, CDCl3): δ  0.86 (t, J  7.3 Hz, 3 H), 1.161.38 (m,
2 H), 1.461.70 (m, 2 H), 2.00 (br. s, 2 H), 4.28 (t, J  6.8 Hz, 1
H), 7.00 (dt, J  7.7, J  1.5 Hz, 1 H), 7.23 (t, J  7.7 Hz, 1 H),
7.39 (dd, J  7.7, J  1.5 Hz, 1 H), 7.44 (dd, J  7.7, J  1.5 Hz,
1 H) ppm. 13C NMR (50 MHz, CDCl3): δ  13.8 (q), 19.3 (t), 39.9
(t), 53.8 (d), 123.2 (s), 127.0 (d), 127.5 (d), 127.9 (d), 132.5 (d),
144.9 (s) ppm. MS (CI): m/z  228 (63.2) [M  H], 230 (61.2)
[M  H].
(1R)-1-(3-Bromophenyl)-1-butylamine (78): Orange oil, 99% yield,
99:1 er. 1H NMR (300 MHz, CDCl3): δ  7.10 (t, J  7.7 Hz, 1
H), 7.15 (d, J  7.7 Hz, 1 H), 7.15 (d, J  7.7 Hz, 1 H), 7.28 (d,
J  7.7 Hz, 1 H), 7.40 (s, 1 H) ppm. 13C NMR (50 MHz, CDCl3):
δ  13.9 (q), 19.5 (t), 41.6 (t), 55.5 (d), 124.5 (d), 126.4 (d), 126.8
(d), 129.5 (d), 134.1 (s), 148.8 (s) ppm. MS (CI): m/z  228 (100.0)
[M  H], 230 (96.6) [M  H].
(1R)-1-(4-Bromophenyl)-1-butylamine (79): Yellow oil, 85% yield,
99:1 er. 1H NMR (300 MHz, CDCl3): δ  0.81 (t, J  7.3 Hz, 3
H), 1.041.33 (m, 2 H), 1.431.56 (m  br. s, 4 H), 3.78 (t, J 
6.8 Hz, 1 H), 7.15 (d, J  8.1 Hz, 2 H), 7.35 (d, J  8.1 Hz, 2 H)
ppm. 13C NMR (50 MHz, CDCl3): δ  13.9 (q), 19.4 (t), 41.6 (t),
55.3 (d), 120.2 (s), 128.2 (d), 131.3 (d), 150.9 (s) ppm. MS (CI):
m/z  228 (95.8) [M  H], 230 (100.0) [M  H].
(1R)-1-[(1,1-Biphenyl)-3-yl]butylamine (80): Pale green oil, 93%
yield. 1H NMR (300 MHz, CDCl3): δ  0.88 (t, J  7.3 Hz, 3 H),
1.151.41 (m, 2 H), 1.611.73 (m, 2 H), 2.14 (br. s, 2 H), 3.92 (t,
J  7.0 Hz, 1 H), 7.257.45 (m, 6 H), 7.51 (s, 1 H), 7.59 (d, J 
7.0 Hz, 2 H) ppm. 13C NMR (50 MHz, CDCl3): δ  11.6 (q), 17.3
(t), 39.3 (t), 53.6 (d), 123.0 (d), 122.8 (d), 123.3 (d), 124.7 (d), 124.8
(d), 126.2 (d), 126.4 (d), 138.8 (s), 138.9 (s), 144.5 (s) ppm. MS
(CI): m/z  226 [M  H].
(1R)-1-[(1,1-Biphenyl)-4-yl]butylamine (81): Orange oil, 95% yield.
1H NMR (300 MHz, CDCl3): δ  0.82 (t, J  7.3 Hz, 3 H),
1.201.41 (m, 2 H), 1.551.68 (m br. s, 4 H), 3.89 (t, J  7.0 Hz,
1 H), 7.277.41 (m, 7 H), 7.54 (t, J  8.4 Hz, 2 H) ppm. 13C NMR
(50 MHz, CDCl3): δ  13.8 (q), 19.4 (t), 41.5 (t), 55.4 (d), 126.5
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(d), 126.7 (d), 126.8 (d), 128.4 (d), 139.3 (s), 140.6 (s), 145.6 (s)
ppm. MS (CI): m/z  226 [M  H].
Synthesis of the Nitro-Substituted Phenylbutylamines (R)-82 and
(R)-83: Enantiomerically pure (R)-1-phenylbutylamine (47;
35 mmol, 5.22 gram) was cautiously added with continuous stirring
during 10 minutes to 30 mL of HNO3 at 5 °C. Heat was gener-
ated, but the temperature was maintained at 5 °C. The reaction
was followed by 1H NMR spectroscopy, and the reaction was com-
plete after stirring at 5 °C for 1 hour. The reaction mixture was
poured onto 100 g of crushed ice and carefully adjusted to pH 10
with aqueous NaOH (33%). The aqueous layer was extracted with
CH2Cl2 and dried over sodium sulfate. Removal of the solvent pro-
vided a mixture of (R)-82 and (R)-83 in a ratio of 22:78 and this
mixture of regioisomers was used without further purification.
(1R)-1-Butyl-1-(2-nitrophenyl)amine (82): Yellow oil, 20% yield. 1H
NMR (300 MHz, CDCl3): δ  0.86 (t, J  7.1 Hz, 3 H), 1.141.36
(m, 2 H), 1.551.84 (m, 2 H), 1.96 (br. s, 2 H), 3.99 (t, J  6.8 Hz,
1 H), 7.407.63 (m, 2 H), 8.038.26 (m, 2 H) ppm. 13C NMR
(50 MHz, CDCl3): δ  13.8 (q), 19.3 (t), 41.4 (t), 55.3 (d), 121.3
(d), 121.9 (d), 129.2 (d), 132.7 (d), 146.8 (s), 148.2 (s), 153.0 (s)
ppm. MS (CI): m/z  195 [M  H].
(1R)-1-Butyl-1-(4-nitrophenyl)amine (83): Yellow oil, 75% yield. 1H
NMR (300 MHz, CDCl3): δ  0.85 (t, J  7.1 Hz, 3 H), 1.171.34
(m, 2 H), 1.47 (br. s, 2 H), 1.511.63 (m, 2 H), 3.98 (t, J  6.8 Hz,
1 H), 7.44 (d, J  8.8 Hz, 2 H), 8.12 (t, J  8.8 Hz, 2 H) ppm. 13C
NMR (50 MHz, CDCl3): δ  13.8 (q), 19.3 (t), 41.7 (t), 55.4 (d),
123.5 (d), 127.1 (d), 146.2 (s), 154.3 (s) ppm. MS (CI): m/z  195
[M  H].
1-(3-Nitrophenyl)-1-butanone (85): Commercially available butyro-
phenone (169 mmol, 25.0 g) was cautiously added with continuous
stirring during 30 minutes at 150 mL of HNO3 at 5 °C. Heat
was generated, but the temperature was maintained at 5 °C. The
reaction was followed by 1H NMR spectroscopy, and the reaction
was complete after stirring at 5 °C for 4 hours. When poured
onto 500 g of crushed ice, the crude m-nitro-compound precipitated
as a yellow curdled solid. After suction filtration, the residue was
dissolved in 200 mL of diethyl ether and dried over sodium sulfate.
After removal of the diethyl ether a yellow oil was obtained, from
which the crude m-nitro compound separated on standing as yellow
plates. After removal of the oil, the yellow plates were recrystallised
once from absolute alcohol. Pure 85 was obtained as pale yellow
plates (92.9 mmol, 18.0 g, 55% yield. M.p. 60.5 °C (ref.[28a] 61 °C).
1H NMR (300 MHz, CDCl3): δ  0.91 (t, J  7.3 Hz, 3 H),
1.631.75 (m, 2 H), 2.92 (t, J  7.1 Hz, 2 H), 7.59 (dt, J  8.1 Hz,
1 H), 8.19 (d, J  7.7 Hz, 1 H), 8.28 (d, J  8.1 Hz, 1 H), 8.63 (s,
1 H) ppm. 13C NMR (50 MHz, CDCl3): δ  13.6 (q), 17.2 (t), 40.5
(t), 122.7 (d), 127.0 (d), 129.8 (d), 139.5 (d), 138.1 (s), 148.2 (s),
197.9 (s) ppm. C10H11NO3 (193.2): calcd. C 62.17, H 5.74, N 7.25;
found C 62.15, H 5.68, N 7.32. MS (EI): m/z  193 [M].
()-1-Butyl-1-(3-nitrophenyl)formamide (86): A mixture of 1-(3-
nitrophenyl)-1-butanone (85; 129 mmol, 25.0 g), 77 mL of formam-
ide and 35 mL of formic acid was heated to reflux. The mixture
was refluxed for several hours until the reaction was complete (fol-
lowed by 1H NMR spectroscopy). After cooling to ambient tem-
perature, 200 mL of water was added and the mixture was extracted
with diethyl ether (3  100 mL). The combined organic layers were
washed with brine, dried over Na2SO4 and concentrated to furnish
a red oil (129 mmol, 28.7 gram, 99% yield). 1H NMR (300 MHz,
CDCl3): δ  0.80 (t, J  7.3 Hz, 3 H), 1.111.36 (m, 2 H),
1.581.75 (m, 2 H), 4.98 (dd, J  15.0, J  7.7 Hz, 1 H), 7.31 (br.
s, 1 H), 7.38 (t, J  8.1 Hz, 1 H), 7.54 (d, J  7.7 Hz, 1 H), 7.97
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(d, J  8.1 Hz, 1 H), 8.07 (s, 1 H), 8.09 (s, 1 H) ppm. 13C NMR
(50 MHz, CDCl3): δ  13.4 (q), 19.1 (t), 37.9 (t), 51.8 (d), 121.0
(d), 122.2 (d), 129.5 (d), 133.1 (d), 144.2 (s), 148.2 (s), 162.2 (d)
ppm. MS (CI): m/z  223 [M  H].
()-1-Butyl-1-(3-nitrophenyl)amine (87): A mixture of -86
(129 mmol, 28.7 gram) and 100 mL of aqueous HCl (30%) was
heated to reflux. The mixture was refluxed overnight. After cooling
to ambient temperature, 200 mL of water was added. The reaction
mixture was carefully adjusted to pH 10 with aqueous NaOH
(33%) and extracted with diethyl ether (3  100 mL). The com-
bined organic layers were washed with brine, dried over Na2SO4
and concentrated to furnish a red oil.
Resolution of ()-87 with (S)-88: One equivalent of (S)-88 was ad-
ded to a solution of the racemic substrate (20.3 mmol, 3.95 g) in
40.6 mL of 2-butanone and 20.3 mL of H2O. The mixture was
heated until a clear solution was obtained. While stirring, the solu-
tion was allowed to cool to room temperature overnight. The salt
was removed by filtration under suction and washed with a little
iPrOH. The salt obtained was recrystallised twice from iPrOH/H2O
(2:1). The salt was shown to contain (R)-87 of 99% ee by HPLC
analysis.[23] The purified salt was treated with 6  NaOH solution
to liberate the free amine (R)-87 of 99% ee in 24% yield from
()-87. [α]D25  5.4 (c  2.15, CHCl3). 1H NMR (200 MHz,
CDCl3): δ  0.77 (t, J  7.3 Hz, 3 H), 1.041.29 (m, 2 H),
1.471.58 (m  br. s, 4 H), 3.91 (t, J  6.8 Hz, 1 H), 7.35 (t, J 
7.7 Hz, 1 H), 7.55 (d, J  7.7 Hz, 1 H), 7.92 (d, J  7.7 Hz, 1 H),
7.92 (d, J  8.1 Hz, 1 H), 8.068.09 (m, 1 H) ppm. 13C NMR
(50 MHz,CDCl3): δ  19.2 (q), 13.7 (t), 41.6 (t), 55.2 (d), 121.2 (d),
121.6 (d), 129.0 (d), 132.6 (d), 148.1 (s), 148.8 (s) ppm.
C10H14N2O2·C11H15O4P: calcd. C 57.79, H 6.70, N 6.42; found C
57.57, H 6.90, N 6.31. MS (CI): m/z  195 [M  H].
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